Hypermobility syndrome

M13_HYPERMOBILITY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M35.7 Cause of death: ICD-10 — M35.7 2 out of 7 registries used, show all original rules.	2265
4. Check minimum number of events None	2265
5. Include endpoints None	2265
6. Filter based on genotype QC (FinnGen only)	2199

Control definitions (FinnGen only)

Control exclude: M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M35
Name in latin: Syndroma hypermobilitatis

NAME	M13_HYPERMOBILITY
CONTROL_EXCLUDE	M13_SYSTCONNECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M357
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M357
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypermobility syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	12843	11010	1784
Only index persons	12485	10796	1689
Unadjusted period prevalence (%)
Whole population	0.28	0.32	0.05
Only index persons	0.35	0.40	0.06
Median age at first event (years)
Whole population	34.47	36.00	25.00
Only index persons	34.85	36.20	26.18

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2199	2049	150
Unadjusted period prevalence (%)	0.68	0.73	0.07
Median age at first event (years)	38.35	38.37	38.15

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2265: Matched controls
22650

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M35.7

ICD-10 Finland

Hypermobility syndrome

4503599627370496.0

307.7

2263

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

112.3

307.7

223

M79.7

ICD-10 Finland

Fibromyalgia

11.0

307.7

426

468

M79.0

ICD-10 Finland

Rheumatism, unspecified

13.6

307.7

364

315

N06AX21

ATC

duloxetine; oral

5.6

289.9

715

1732

M25.5

ICD-10 Finland

Pain in joint

4.7

289.6

1383

5645

N03AX16

ATC

[U] pregabalin

4.6

263.3

908

2864

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.3

237.3

460

882

N03AX12

ATC

[U] gabapentin; oral

4.6

223.2

685

1945

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

5.6

198.3

431

912

N02AX02

ATC

tramadol; systemic, rectal

3.5

187.7

1222

5675

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

41.5

176.9

107

P01BA02

ATC

hydroxychloroquine; oral

5.5

174.5

381

805

M54.5

ICD-10 Finland

Low back pain

3.3

172.3

1288

6407

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

5.3

159.5

364

797

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

10.8

156.3

174

173

M54.4

ICD-10 Finland

Lumbago with sciatica

3.5

153.3

722

2682

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.4

147.9

429

1138

L04AX03

ATC

methotrexate; systemic

4.3

137.5

407

1093

L28

ICPC

Limited function/disability (L)

4.0

136.4

469

1404

R4120

NOMESCO Finland

Occupational therapy

5.3

136.1

303

646

H02AB06

ATC

prednisolone; systemic

2.9

134.5

1305

7189

M01AH01

ATC

celecoxib; oral

3.6

134.4

550

1851

N06AA09

ATC

amitriptyline; systemic

4.4

123.2

351

912

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

7.9

121.9

174

237

A01

ICPC

Pain general/multiple sites

4.2

121.1

372

1022

M79.1

ICD-10 Finland

Myalgia

3.2

118.0

624

2438

M79.6

ICD-10 Finland

Pain in limb

2.7

117.2

1263

7172

N06AX16

ATC

venlafaxine; oral

3.1

116.9

634

2512

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.9

116.2

396

1170

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.7

115.8

1238

6988

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

115.2

758

3340

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.7

114.7

1242

7045

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.4

114.0

501

1748

R51.80

ICD-10 Finland

Headache

3.0

113.6

694

2934

A07EC01

ATC

sulfasalazine; oral, rectal

4.1

109.3

337

925

M03BC01

ATC

orphenadrine (citrate); systemic

2.7

107.2

826

3927

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.0

106.2

340

958

M01AH05

ATC

etoricoxib; oral

2.8

103.5

1664

11227

A02BC02

ATC

pantoprazole; systemic

2.8

101.9

1665

11281

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.2

101.5

481

1747

G54.0

ICD-10 Finland

Brachial plexus disorders

5.8

100.9

193

356

M70.6

ICD-10 Finland

Trochanteric bursitis

3.2

91.7

434

1568

M54.6

ICD-10 Finland

Pain in thoracic spine

3.6

91.4

339

1052

G44.2

ICD-10 Finland

Tension-type headache

2.8

90.9

571

2414

UJF32

NOMESCO Finland

Coloscopy

2.8

90.7

606

2645

M01AC06

ATC

meloxicam; systemic, rectal

2.4

88.5

935

5069

L20

ICPC

Joint symptom/complaint NOS

5.2

88.4

190

389

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

87.0

748

3685

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.2

85.9

251

658

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.1

85.8

258

691

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.1

85.1

434

1632

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.3

84.6

233

584

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

8.8

84.6

108

128

L03

ICPC

Low back symptom/complaint

2.4

84.2

884

4756

R52.2

ICD-10 Finland

Other chronic pain

5.2

83.7

183

380

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.9

83.3

486

1967

M03BX02

ATC

tizanidine; oral

2.6

82.1

1690

12111

R4110

NOMESCO Finland

Physiotherapy

2.5

81.9

713

3517

ZYC01

NOMESCO Finland

Remote contact by phone

3.9

81.6

259

720

R52.9

ICD-10 Finland

Pain, unspecified

3.3

81.2

340

1136

R06.0

ICD-10 Finland

Dyspnoea

2.5

79.6

657

3155

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

77.3

574

2616

M54.2

ICD-10 Finland

Cervicalgia

3.3

76.1

317

1053

SPAT1229

SPAT

Assessment of need for aid

4.5

75.9

197

471

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

75.5

546

2453

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

6.2

75.4

133

226

ZX140

NOMESCO Finland

Intra articular

13.0

75.4

Z01.8

ICD-10 Finland

Other specified special examinations

2.5

74.9

636

3081

R03AC02

ATC

salbutamol; inhalant

2.3

74.8

1537

10776

A02BC05

ATC

esomeprazole; systemic

2.2

74.4

1028

6131

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

74.1

257

758

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

73.9

451

1859

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

71.0

220

600

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

70.6

403

1600

N06AX11

ATC

mirtazapine; oral

2.2

70.4

938

5481

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

70.2

318

1109

M45

ICD-10 Finland

Ankylosing spondylitis

6.5

69.2

115

184

M50.3

ICD-10 Finland

Other cervical disc degeneration

7.0

69.0

108

162

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

69.0

654

3311

Z50.1

ICD-10 Finland

Other physical therapy

4.4

68.1

181

440

N02BF02

ATC

pregabalin; oral

3.7

67.9

228

657

R20.2

ICD-10 Finland

Paraesthesia of skin

3.2

67.7

292

988

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.8

67.7

159

350

K07.60

ICD-10 Finland

Snapping jaw

3.3

67.6

284

946

M13.9

ICD-10 Finland

Arthritis, unspecified

3.4

66.5

260

828

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

65.6

857

4936

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.1

65.6

304

1073

M01AB05

ATC

diclofenac; systemic, rectal

2.3

65.0

1616

11897

N02BF01

ATC

gabapentin; oral

3.3

64.7

274

916

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.5

64.5

518

2427

L88

ICPC

Rheumatoid/seropositive arthritis

4.6

64.3

158

361

M01AE02

ATC

naproxen; oral, rectal

2.2

64.2

1569

11443

M47.82

ICD-10 Finland

Other spondylosis, cervical region

5.0

63.7

143

303

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

81.5

63.4

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.9

62.9

144

310

N05AH04

ATC

quetiapine; oral

2.3

61.6

595

3016

R42

ICD-10 Finland

Dizziness and giddiness

2.4

60.6

540

2642

Z71.8

ICD-10 Finland

Other specified counselling

2.1

60.5

954

5860

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.3

60.3

601

3084

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

60.2

784

4480

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

60.0

338

1326

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.5

60.0

154

364

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

59.4

559

2798

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.0

59.3

291

1058

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.8

59.2

342

1359

Z31.5

ICD-10 Finland

Genetic counselling

3.1

59.1

278

987

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

59.0

609

3168

R03DC03

ATC

montelukast; oral

2.3

58.3

555

2788

TEA00

NOMESCO Finland

Biopsy of lip

14.3

58.0

N03AX09

ATC

lamotrigine; oral

3.2

57.5

244

815

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

57.3

880

5328

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.2

56.7

251

859

M02AA07

ATC

piroxicam; topical

2.1

56.6

762

4388

R02

ICPC

Shortness of breath/dyspnoea

2.7

56.6

343

1395

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

56.0

845

5074

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.3

55.9

521

2589

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

55.7

1084

7120

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

55.7

867

5261

C07AB07

ATC

bisoprolol; oral

2.1

55.5

804

4753

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

5.8

55.4

103

184

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

55.1

284

1060

M53.2

ICD-10 Finland

Spinal instabilities

10.4

54.8

N02BE01

ATC

paracetamol; systemic, rectal

3.3

54.7

2085

17673

N06AA10

ATC

nortriptyline; systemic

5.5

54.6

109

208

XA402

NOMESCO Finland

ENMG

5.6

54.3

106

198

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.3

54.3

145

353

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.5

54.1

413

1876

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

53.9

657

3632

K30

ICD-10 Finland

Functional dyspepsia

2.6

53.7

373

1621

M35.3

ICD-10 Finland

Polymyalgia rheumatica

10.6

53.6

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

53.6

474

2299

A02BC03

ATC

lansoprazole; oral

2.1

53.5

638

3495

R06AE07

ATC

cetirizine; oral

2.0

53.0

1266

8872

L17

ICPC

Foot/toe symptom/complaint

2.1

53.0

730

4222

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

52.9

520

2636

M24.2

ICD-10 Finland

Disorder of ligament

6.5

52.8

141

L01BA01

ATC

methotrexate; systemic

4.3

51.5

136

328

M01AX17

ATC

nimesulide; oral

2.3

51.5

481

2384

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.9

51.2

270

1019

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.1

50.9

237

834

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.6

50.8

174

506

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

50.6

899

5670

M25.2

ICD-10 Finland

Flail joint

6.5

50.1

132

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

8.4

49.8

C07AA05

ATC

propranolol; systemic

2.1

49.7

663

3772

N02AA05

ATC

oxycodone; systemic

2.7

49.5

294

1180

M01AB08

ATC

etodolac; oral

3.2

48.9

211

710

WZC30

NOMESCO Finland

Teaching

2.4

48.7

372

1685

Z3226

NOMESCO Finland

Physiotherapist

2.3

48.6

458

2273

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

6.8

48.6

117

J01AA02

ATC

doxycycline; systemic

2.1

48.5

1763

14081

L02

ICPC

Back symptom/complaint

2.5

48.2

363

1632

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

48.2

594

3277

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.1

48.1

104

213

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

48.0

331

1428

M01AH02

ATC

rofecoxib; oral

2.8

48.0

263

1011

L01

ICPC

Neck symptom/complaint

2.2

47.7

507

2639

A02BA02

ATC

ranitidine; systemic

2.4

47.5

397

1870

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.7

47.4

157

446

N05BA04

ATC

oxazepam; oral

2.0

47.2

701

4133

R53

ICD-10 Finland

Malaise and fatigue

2.0

47.2

677

3943

ZX120

NOMESCO Finland

Intravenous

2.9

47.1

241

893

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

47.0

460

2315

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

46.9

339

1495

L99

ICPC

Musculoskeletal disease other

5.4

46.9

180

G43.3

ICD-10 Finland

Complicated migraine

4.3

46.7

123

296

H02AB07

ATC

prednisone; oral

2.5

46.6

334

1467

L29

ICPC

Musculoskeletal sympt/complt other

2.8

46.5

255

980

A02BC01

ATC

omeprazole; systemic

2.0

46.0

635

3642

N06AB04

ATC

citalopram; systemic

2.1

45.9

562

3084

L15

ICPC

Knee symptom/complaint

2.1

45.8

600

3376

G50.1

ICD-10 Finland

Atypical facial pain

5.7

45.8

155

G47.3

ICD-10 Finland

Sleep apnoea

2.2

45.6

465

2377

L04AA13

ATC

[U] leflunomide

4.9

45.1

101

213

R03BA05

ATC

fluticasone; inhalant

2.1

45.1

531

2870

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.0

45.0

216

772

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

44.7

341

1539

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.9

44.6

102

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

44.3

1077

7431

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

5.4

44.0

168

C01CA24

ATC

epinephrine; parenteral

2.7

43.9

267

1081

P01AB01

ATC

metronidazole; oral, rectal

1.9

43.9

1077

7445

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.4

43.8

165

510

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

43.7

552

3058

N06AX12

ATC

bupropion; oral

2.5

43.5

305

1324

Z02.7

ICD-10 Finland

Issue of medical certificate

2.9

43.2

217

795

R96

ICPC

Asthma

2.6

43.1

276

1146

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

43.0

268

1099

M47.9

ICD-10 Finland

Spondylosis, unspecified

5.1

42.6

188

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

42.4

281

1186

L16

ICPC

Ankle symptom/complaint

2.3

42.3

371

1777

L13

ICPC

Hip symptom/complaint

2.2

41.9

396

1957

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

5.7

41.9

143

L04AB04

ATC

adalimumab; parenteral

4.2

41.7

113

278

ZXH09, ,

SPAT

4.0

41.6

122

318

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

5.3

41.6

162

M22.4

ICD-10 Finland

Chondromalacia patellae

3.6

41.5

144

422

L12

ICPC

Hand/finger symptom/complaint

2.1

41.4

476

2540

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

41.4

468

2482

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

41.3

897

5940

M54.3

ICD-10 Finland

Sciatica

3.1

41.2

185

636

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.1

41.1

182

620

M54.8

ICD-10 Finland

Other dorsalgia

3.2

41.0

171

563

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.4

40.7

305

1363

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

40.2

377

1855

3007

Kela drug reimbursment

Erenumab and fremanezumab

4.6

40.1

214

ZY010

NOMESCO Finland

Hospital outpatient

2.8

40.1

220

844

F34.1

ICD-10 Finland

Dysthymia

3.3

40.1

158

502

R52.1

ICD-10 Finland

Chronic intractable pain

7.9

40.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.8

39.7

212

802

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.1

39.5

113

289

N03AE01

ATC

clonazepam; systemic

3.2

39.5

163

533

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.3

39.5

158

507

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

39.3

346

1657

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

5.3

39.1

156

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

5.6

39.0

138

C09CA06

ATC

candesartan; oral

2.0

38.7

522

2945

L08

ICPC

Shoulder symptom/complaint

2.0

38.7

504

2809

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.4

38.5

281

1239

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.2

38.5

163

541

XKD00

NOMESCO Finland

Uroflowmetry

3.5

38.5

139

418

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

38.4

269

1164

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.7

38.3

125

351

Z3231

NOMESCO Finland

Registered nurse

1.9

38.3

613

3665

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

5.6

38.3

137

SPAT1240

SPAT

Therapeutic discussion

2.1

38.3

416

2167

T78.4

ICD-10 Finland

Allergy, unspecified

2.8

38.2

199

742

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.2

38.1

375

1878

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.5

38.1

223

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.7

38.1

230

926

J01FF01

ATC

clindamycin; systemic

1.9

38.1

628

3790

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

6.0

37.8

114

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

7.1

37.8

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.1

37.7

168

574

M54.1

ICD-10 Finland

Radiculopathy

3.5

37.7

133

394

R4110, ,

SPAT

2.7

37.5

223

891

R01AD09

ATC

mometasone; nasal

1.8

37.4

1251

9319

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.4

37.3

139

426

J01FA06

ATC

roxithromycin; oral

1.8

37.2

938

6439

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

37.2

387

1980

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.8

37.0

200

761

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

36.7

167

578

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

36.7

356

1772

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

36.6

647

3985

M43.1

ICD-10 Finland

Spondylolisthesis

3.7

36.5

120

339

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

5.9

36.4

115

N03AX11

ATC

topiramate; oral

3.5

36.1

128

380

N06AB03

ATC

fluoxetine; oral

2.2

36.0

368

1868

J01FA10

ATC

azithromycin; systemic

1.8

36.0

1568

12543

XF404

NOMESCO Finland

Ambulatory ECG

2.9

36.0

176

634

WZC30, ,

SPAT

3.2

35.9

148

483

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.5

35.7

256

1118

R03AC03

ATC

terbutaline; inhalant

2.1

35.7

394

2060

N06AB10

ATC

escitalopram; oral

1.8

35.4

667

4184

ZXA00

NOMESCO Finland

Right side

2.0

35.4

481

2712

N06AX22

ATC

agomelatine; oral

3.7

35.4

113

313

M48.0

ICD-10 Finland

Spinal stenosis

2.8

35.2

189

716

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.6

35.2

224

925

M54

ICD-10 Finland

Dorsalgia

2.1

34.9

387

2026

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

34.9

199

778

AA1AD

NOMESCO Finland

CT of head and brain

2.0

34.8

439

2408

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.1

34.7

244

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.4

34.6

130

401

G44.0

ICD-10 Finland

Cluster headache syndrome

5.7

34.5

114

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

34.4

443

2447

ZXA05

NOMESCO Finland

Left side

2.0

34.4

446

2471

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.2

34.3

348

1759

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

4.7

34.0

176

M79.8

ICD-10 Finland

Other specified soft tissue disorders

8.4

33.9

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

33.7

135

433

M89.0

ICD-10 Finland

Algoneurodystrophy

6.6

33.7

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.2

33.7

333

1666

XQ800

NOMESCO Finland

Prick test

2.3

33.7

282

1318

M22.0

ICD-10 Finland

Recurrent dislocation of patella

4.6

33.5

178

N05BA01

ATC

diazepam; systemic, rectal

2.2

33.5

306

1483

M01AX05

ATC

glucosamine; oral

2.3

33.5

282

1321

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.0

33.5

152

525

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

33.3

315

1548

L04AB01

ATC

etanercept; parenteral

4.6

33.3

175

R11

ICD-10 Finland

Nausea and vomiting

2.3

33.1

262

1195

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.0

33.0

244

R03BA01

ATC

beclometasone; inhalant

2.1

33.0

348

1785

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

6.1

32.9

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

6.2

32.8

R00.2

ICD-10 Finland

Palpitations

2.3

32.7

261

1194

ZY010, ,

SPAT

6.0

32.7

Z2445

NOMESCO Finland

Psychologist

2.9

32.6

159

572

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.4

32.5

122

376

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

32.3

1835

15605

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

32.3

611

3821

XA800

NOMESCO Finland

Neuropsychological investigation

3.3

32.1

127

404

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

32.1

527

3151

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.6

32.1

192

768

R03BA02

ATC

budesonide; inhalant

1.9

32.1

477

2762

C08DA01

ATC

verapamil; systemic

3.8

32.0

268

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.0

31.8

146

507

L04AX01

ATC

azathioprine; systemic

3.3

31.8

125

396

UKC02

NOMESCO Finland

Cystoscopy

2.5

31.7

211

889

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.9

31.4

253

R1250

NOMESCO Finland

Evaluation of functional capability

4.5

31.4

175

G93.3

ICD-10 Finland

Postviral fatigue syndrome

7.3

31.4

X58

ICD-10 Finland

Exposure to other specified factors

2.0

31.3

365

1941

M01AX01

ATC

nabumetone; oral

3.7

31.2

102

287

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

31.2

1217

9268

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

31.1

391

2136

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.2

31.0

125

402

J45

ICD-10 Finland

Asthma

2.2

31.0

300

1485

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

30.9

412

2296

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

30.9

562

3466

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.1

30.5

132

443

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.4

30.3

215

933

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.7

30.3

103

J02AC01

ATC

fluconazole; systemic

1.7

30.2

1172

8882

R07.3

ICD-10 Finland

Other chest pain

2.4

30.1

235

1063

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.5

30.0

108

324

N04BC05

ATC

pramipexole; oral

2.8

30.0

163

621

WX002

NOMESCO Finland

Sedation and analgesia

2.0

29.8

371

2016

J01FA09

ATC

clarithromycin; systemic

1.7

29.6

795

5467

J01EA01

ATC

trimethoprim; systemic

1.7

29.4

681

4494

M53.8

ICD-10 Finland

Other specified dorsopathies

7.3

29.3

F45.8

ICD-10 Finland

Other somatoform disorders

2.2

29.3

287

1427

Z2446

NOMESCO Finland

Social worker

2.5

29.1

190

793

UJF92

NOMESCO Finland

Capsular endoscopy

4.3

29.0

182

B01AB05

ATC

enoxaparin; parenteral

1.8

29.0

599

3826

ZYC01, ,

SPAT

2.1

28.9

310

1596

R50.9

ICD-10 Finland

Fever, unspecified

2.0

28.8

349

1877

R06.4

ICD-10 Finland

Hyperventilation

4.6

28.8

154

R05

ICPC

Cough

1.8

28.7

621

4015

J01MA02

ATC

ciprofloxacin; systemic

1.7

28.7

730

4937

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

28.7

264

1279

A28

ICPC

Limited function/disability NOS

2.4

28.7

207

904

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.2

28.7

260

1253

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

28.6

201

868

A04

ICPC

Weakness/tiredness general

1.9

28.6

398

2247

R06AX22

ATC

ebastine; oral

1.8

28.4

497

3017

R4120, ,

SPAT

8.7

28.4

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.7

28.4

164

644

R51.81

ICD-10 Finland

Facial pain NOS

3.7

28.4

262

D07AD01

ATC

clobetasol; topical

2.0

28.3

382

2134

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.8

28.2

235

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.7

28.2

158

611

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

28.1

380

2123

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.7

28.0

157

607

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

28.0

554

3489

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

27.9

132

466

R51

ICD-10 Finland

Headache

2.4

27.9

207

916

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.4

27.8

167

F45.0

ICD-10 Finland

Somatization disorder

9.1

27.7

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.6

27.7

163

646

M01AB55

ATC

diclofenac, combinations; oral

2.9

27.7

133

474

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.5

27.7

155

N05CF01

ATC

zopiclone; oral

1.7

27.7

622

4060

N06BA04

ATC

methylphenidate; oral

2.6

27.5

165

660

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

27.5

977

7183

M03BX01

ATC

baclofen; systemic

4.4

27.5

160

R5110, ,

SPAT

2.9

27.4

130

460

N02CD03

ATC

fremanezumab; systemic

4.6

27.4

144

H02AB04

ATC

methylprednisolone; systemic

2.0

27.4

319

1691

IGY02, ,

SPAT

5.1

27.3

117

WZA10

NOMESCO Finland

Extensive medical or dental certificate

5.0

27.2

121

G43

ICD-10 Finland

Migraine

2.2

27.2

254

1238

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

5.9

27.1

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.5

27.1

280

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

5.0

27.0

118

L86

ICPC

Back syndrome with radiating pain

2.6

27.0

163

654

A02BC04

ATC

rabeprazole; oral

2.2

26.9

242

1162

J01DA01

ATC

[U] cefalexin

1.6

26.8

1419

11472

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.9

26.8

127

449

Z01.9

ICD-10 Finland

Special examination, unspecified

2.7

26.8

148

568

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

26.7

966

7117

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

26.7

1741

14850

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.8

26.6

217

S18

ICPC

Laceration/cut

1.6

26.6

863

6190

Z01.2

ICD-10 Finland

Dental examination

1.6

26.2

1189

9237

N06AX26

ATC

vortioxetine; oral

2.2

26.2

249

1221

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

26.0

189

827

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.3

26.0

102

323

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

25.9

230

1097

A06AD11

ATC

lactulose; oral

2.2

25.9

224

1057

N06AB06

ATC

sertraline; oral

1.9

25.9

361

2034

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

25.8

290

1516

N02AJ13

ATC

tramadol and paracetamol; systemic

4.2

25.6

169

Z00.0

ICD-10 Finland

General medical examination

1.8

25.6

449

2719

P03

ICPC

Feeling depressed

1.9

25.6

377

2162

M01AH03

ATC

valdecoxib; oral

2.8

25.5

133

495

XG466

NOMESCO Finland

Sleep oxymetry

4.2

25.4

170

SPAT1216

SPAT

Assessment of functional ability

2.2

25.4

242

1188

S83.0

ICD-10 Finland

Dislocation of patella

3.4

25.3

288

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

25.2

301

1606

D01

ICPC

Abdominal pain/cramps general

1.9

25.2

358

2028

ZXH06, ,

SPAT

2.9

25.1

125

454

R01AD58

ATC

fluticasone, combinations; nasal

1.6

25.1

750

5251

R03BB04

ATC

tiotropium bromide; inhalant

2.6

25.1

149

593

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.6

25.1

156

635

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

5.2

25.1

H57.1

ICD-10 Finland

Ocular pain

2.8

25.0

133

501

SPAT1301

SPAT

No procedures

1.7

24.9

652

4411

P01

ICPC

Feeling anxious/nervous/tense

1.8

24.9

496

3116

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.5

24.8

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.3

24.7

200

917

M05BA04

ATC

alendronic acid; oral

2.9

24.7

118

419

C10AC01

ATC

colestyramine; oral

3.6

24.7

238

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

5.6

24.6

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

24.6

163

684

M01AE52

ATC

naproxen and esomeprazole; oral

3.3

24.6

293

R5599

NOMESCO Finland

Other rehabilitation service

3.5

24.5

249

SFA10

NOMESCO Finland

One-surface restoration

1.6

24.5

1374

11147

NF1AA

NOMESCO Finland

Hip X-ray examination

2.7

24.3

131

496

K02.1

ICD-10 Finland

Caries of dentine

1.6

24.3

1500

12435

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

24.2

1466

12090

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

8.9

24.2

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

24.1

221

1067

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.0

24.1

107

365

C03CA01

ATC

furosemide; systemic

2.0

24.0

295

1589

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

7.5

23.8

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

23.8

148

603

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.2

23.7

214

1027

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.6

23.7

D06

ICPC

Abdominal pain localized other

2.0

23.5

262

1363

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

23.4

695

4841

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.0

23.4

105

360

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.6

23.4

135

530

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.0

23.3

168

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

23.1

1325

10733

N02CD01

ATC

erenumab; parenteral

4.3

23.1

143

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

3.6

23.1

215

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.8

22.9

111

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.9

22.9

179

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

22.9

174

777

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.6

22.8

212

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

22.7

684

4775

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

22.7

142

580

R03BA08

ATC

ciclesonide; inhalant

2.1

22.6

236

1197

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

5.1

22.6

E0000UV, ,

ATC

1.6

22.6

988

7519

R01AD08

ATC

fluticasone; nasal

1.6

22.6

737

5244

XCK00

NOMESCO Finland

Perimetry

2.8

22.5

115

424

J01DB01

ATC

cefalexin; oral

1.8

22.5

1891

16756

L04AB06

ATC

golimumab; parenteral

5.2

22.4

H03AA01

ATC

levothyroxine sodium; systemic

1.7

22.3

564

3764

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

22.2

1021

7846

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

22.2

177

806

L11

ICPC

Wrist symptom/complaint

2.0

22.2

274

1477

IHZ05, ,

SPAT

2.4

22.0

163

719

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.7

21.9

125

488

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

21.8

220

1101

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.0

21.8

158

N02CC07

ATC

frovatriptan; oral

2.2

21.8

186

871

H02AB09

ATC

hydrocortisone; systemic

3.6

21.8

209

Z08

ICPC

Social welfare problem

4.6

21.8

116

M02AA10

ATC

ketoprofen; topical

1.9

21.7

312

1768

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

21.7

190

900

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

21.7

189

894

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

21.6

709

5042

L40.5

ICD-10 Finland

Arthropathic psoriasis

4.5

21.6

121

R06AX27

ATC

desloratadine; oral

1.6

21.5

828

6104

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

21.5

452

2869

R01AD05

ATC

budesonide; nasal

2.1

21.5

206

1012

N01

ICPC

Headache

1.8

21.5

399

2447

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

21.4

483

3127

N02CC06

ATC

eletriptan; oral

2.4

21.3

153

666

P29

ICPC

Psychological sympt/compl other

2.0

21.3

264

1425

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.6

21.2

128

513

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.7

21.2

114

431

G72.9

ICD-10 Finland

Myopathy, unspecified

9.1

21.2

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.3

21.2

131

R39.1

ICD-10 Finland

Other difficulties with micturition

4.3

21.2

131

SPAT1058

SPAT

PEF monitoring instruction

2.2

21.1

177

823

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.8

21.1

108

398

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

50.5

21.1

S06.0

ICD-10 Finland

Concussion

2.0

21.1

256

1371

G43.8

ICD-10 Finland

Other migraine

3.2

21.1

274

R74

ICPC

Upper respiratory infection acute

1.5

21.0

990

7622

L50.9

ICD-10 Finland

Urticaria, unspecified

2.5

20.9

131

535

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

20.9

480

3119

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

20.9

473

3062

TAB00

NOMESCO Finland

Lumbar puncture

2.6

20.8

129

524

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

6.1

20.8

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

6.1

20.8

M23.8

ICD-10 Finland

Other internal derangements of knee

2.7

20.7

116

449

N02CC04

ATC

rizatriptan; oral

2.1

20.6

217

1104

P76

ICPC

Depressive disorder

2.0

20.6

237

1246

M77.4

ICD-10 Finland

Metatarsalgia

2.2

20.5

180

853

M77.1

ICD-10 Finland

Lateral epicondylitis

2.0

20.5

238

1254

K08.80

ICD-10 Finland

Toothache NOS

1.9

20.5

274

1516

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

20.4

355

2132

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

20.4

239

1264

N02CC03

ATC

zolmitriptan; nasal, oral

2.1

20.4

212

1074

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.2

20.3

131

L18

ICPC

Muscle pain

2.7

20.3

115

447

C07AB02

ATC

metoprolol; systemic

1.9

20.3

266

1462

N81.6

ICD-10 Finland

Rectocele

2.3

20.2

162

739

A03FA02

ATC

cisapride; oral, rectal

2.4

20.1

139

594

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

20.1

156

702

N06AX03

ATC

mianserin; oral

2.7

20.1

110

420

R06.5

ICD-10 Finland

Mouth breathing

2.2

20.0

186

902

R05

ICD-10 Finland

Cough

1.7

20.0

476

3118

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.8

20.0

164

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

20.0

827

6172

S43.0

ICD-10 Finland

Dislocation of shoulder joint

3.0

19.9

299

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

19.9

1250

10176

P06

ICPC

Sleep disturbance

1.8

19.9

314

1831

N03AG01

ATC

valproic acid; systemic, rectal

2.3

19.8

154

694

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.6

19.8

114

447

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.9

19.8

156

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.0

19.8

231

1220

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

19.7

218

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

19.7

228

1199

SPAT1202

SPAT

Intra-articular injection

4.0

19.7

143

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.7

19.7

175

WX722

NOMESCO Finland

PEEP

3.2

19.7

254

J01MA12

ATC

levofloxacin; systemic

1.8

19.6

302

1747

SBB10

NOMESCO Finland

Dental impressions

2.0

19.5

216

1119

R60.0

ICD-10 Finland

Localized oedema

2.1

19.4

208

1064

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.8

19.4

158

M23.5

ICD-10 Finland

Chronic instability of knee

6.4

19.3

UJD02

NOMESCO Finland

Gastroscopy

2.8

19.3

349

N03AF01

ATC

carbamazepine; oral, rectal

2.7

19.3

107

412

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.0

19.2

141

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

19.2

215

1119

SAA04

NOMESCO Finland

Special examination of mouth

2.3

19.1

150

679

N89

ICPC

Migraine

2.2

19.0

168

799

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.6

18.9

100

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.5

18.9

127

536

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

18.8

302

1768

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.7

18.6

158

F60.5

ICD-10 Finland

Anankastic personality disorder

3.8

18.6

149

M15

ICD-10 Finland

Polyarthrosis

2.8

18.6

350

A04AA01

ATC

ondansetron; systemic, rectal

2.1

18.6

173

839

WZC00, ,

SPAT

1.9

18.6

260

1459

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

18.5

214

1125

R25.2

ICD-10 Finland

Cramp and spasm

3.4

18.5

202

R01AD12

ATC

fluticasone furoate; nasal

1.5

18.5

881

6744

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

18.4

136

599

XF402

NOMESCO Finland

ECG with work load test

2.3

18.4

141

632

SPAT1310

SPAT

Counselling related to known health issue

1.5

18.3

707

5173

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

18.3

220

1172

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

18.3

159

750

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.7

18.3

365

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.5

18.3

189

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

4.5

18.2

SPAT1284

SPAT

Extensive health certificate

2.8

18.2

332

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.4

18.1

125

534

M22.1

ICD-10 Finland

Recurrent subluxation of patella

5.8

18.1

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

18.1

601

4255

SPAT1325

SPAT

Vaccination

1.6

18.0

619

4414

SFA20

NOMESCO Finland

Two-surface restoration

1.5

18.0

1422

12017

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

18.0

118

493

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.7

17.9

153

N05CF02

ATC

zolpidem; oral

1.7

17.9

398

2554

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

6.7

17.9

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

17.8

147

679

S29

ICPC

Skin symptom/complaint other

1.7

17.8

395

2533

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.6

17.8

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

17.7

J01DA09

ATC

[U] cefadroxil

1.6

17.7

607

4323

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

17.6

214

1144

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

17.6

145

670

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.4

17.6

189

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.7

17.5

350

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

17.5

678

4956

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

6.6

17.5

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

6.8

17.4

A29

ICPC

General symptom/complaint other

1.9

17.3

249

1407

J46

ICD-10 Finland

Status asthmaticus

3.0

17.3

274

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

4.6

17.3

SPAT1260

SPAT

Consultation of another employee

1.7

17.3

364

2301

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

17.2

259

1485

SPAT1153

SPAT

Removal of sutures

1.6

17.2

527

3656

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

17.1

126

554

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

17.1

827

6322

SPAT1106

SPAT

Acupuncture

5.3

17.0

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

17.0

510

3520

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

16.9

323

1988

RF120, ,

NOMESCO Finland

4.8

16.8

I73.0

ICD-10 Finland

Raynaud syndrome

3.5

16.8

165

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

16.7

110

460

K80

ICPC

Cardiac arrhythmia NOS

2.1

16.7

157

764

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.7

16.6

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.8

16.6

138

S03.0

ICD-10 Finland

Dislocation of jaw

5.3

16.6

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.7

16.5

326

M25.3

ICD-10 Finland

Other instability of joint

7.3

16.5

RS222, ,

NOMESCO Finland

5.0

16.4

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

16.4

137

636

N30.0

ICD-10 Finland

Acute cystitis

1.6

16.4

413

2730

M43.0

ICD-10 Finland

Spondylolysis

3.7

16.4

144

N02CC05

ATC

almotriptan; oral

2.1

16.4

151

730

TAB20

NOMESCO Finland

Epidural puncture

5.7

16.3

J35.0

ICD-10 Finland

Chronic tonsillitis

1.9

16.3

210

1145

1220

FHL

Arthroscopy

2.8

16.2

284

R29

ICPC

Respiratory symptom/complaint other

2.1

16.2

165

828

F84.5

ICD-10 Finland

Asperger syndrome

5.1

16.2

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.3

16.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

16.2

132

607

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.3

16.2

189

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

6.8

16.1

ZXA10

NOMESCO Finland

Bilateral

1.7

16.0

323

2014

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.6

16.0

390

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

16.0

129

590

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.0

16.0

186

979

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.7

16.0

137

R06AX13

ATC

loratadine; oral

1.6

16.0

423

2830

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.4

15.9

166

SPAT1059

SPAT

Spirometry at the office

2.5

15.9

102

422

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.3

15.9

116

509

N07CA01

ATC

betahistine; oral

2.3

15.8

116

510

N06BA12

ATC

lisdexamfetamine; oral

3.5

15.8

162

M25.9

ICD-10 Finland

Joint disorder, unspecified

4.2

15.8

R06AE09

ATC

levocetirizine; oral

1.6

15.8

398

2630

IHZ04, ,

SPAT

3.8

15.8

129

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.4

15.8

111

479

K07.68

ICD-10 Finland

Other disorders of the jaw joint

4.3

15.7

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.0

15.7

229

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.5

15.7

388

M05BA07

ATC

risedronic acid; oral

4.1

15.7

107

R4190

NOMESCO Finland

Nutritional therapy

2.5

15.6

383

JAH01

NOMESCO Finland

Laparoscopy

2.2

15.6

140

669

F48.0

ICD-10 Finland

Neurasthenia

17.3

15.6

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

15.6

1691

14983

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

15.5

178

933

OAA68, ,

SPAT

3.7

15.4

131

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

15.4

234

1344

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

5.4

15.4

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

12.4

15.3

R07.0

ICD-10 Finland

Pain in throat

1.9

15.3

216

1212

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.9

15.3

260

N05CD07

ATC

temazepam; oral

2.1

15.3

149

736

9245

FHL

Reconstruction or plastic surgery of ankle ligaments

7.0

15.3

A02BA04

ATC

nizatidine; systemic

2.3

15.3

116

518

SPAT1283

SPAT

Restricted health certificate

1.5

15.2

621

4564

WW200, ,

SPAT

1.6

15.2

448

3068

J01

ICD-10 Finland

Acute sinusitis

2.0

15.2

180

953

N06AX17

ATC

milnacipran; oral

4.1

15.2

101

Z00.8

ICD-10 Finland

Other general examinations

1.9

15.2

188

1012

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

15.2

112

494

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

15.1

110

482

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

15.1

132

625

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

15.0

366

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

15.0

378

ZX114

NOMESCO Finland

Intramuscular

3.9

15.0

115

SPAT1312

SPAT

General health counselling

1.5

15.0

747

5707

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

15.0

381

2520

R03BB01

ATC

ipratropium bromide; inhalant

3.4

14.9

163

A03

ICPC

Fever

1.5

14.9

481

3362

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

14.9

127

595

M02AA15

ATC

diclofenac; topical

2.2

14.9

130

615

R21

ICPC

Throat symptom/complaint

1.5

14.9

670

5020

J20

ICD-10 Finland

Acute bronchitis

1.8

14.8

233

1352

E66.8

ICD-10 Finland

Other obesity

2.0

14.8

173

913

SPAT1211

SPAT

Application of soft bandage

1.9

14.7

186

1007

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

14.7

543

3905

M15.8

ICD-10 Finland

Other polyarthrosis

3.8

14.7

117

XG405

NOMESCO Finland

Education on PEF monitoring

3.9

14.7

108

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.4

14.7

407

K07.61

ICD-10 Finland

Cracking jaw joint

2.6

14.7

329

B02AA02

ATC

tranexamic acid; systemic

1.6

14.7

433

2966

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.3

14.7

118

540

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.2

14.6

125

586

G04BD12

ATC

mirabegron; oral

2.0

14.6

153

776

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.8

14.5

273

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.6

14.5

132

J01FA01

ATC

erythromycin; systemic

1.6

14.5

386

2580

ZXE00

NOMESCO Finland

One hour or less

1.4

14.5

842

6613

ZX100

NOMESCO Finland

Oral

4.6

14.5

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.5

14.5

355

J45.8

ICD-10 Finland

Mixed asthma

2.8

14.4

274

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.7

14.4

280

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

5.2

14.4

R55

ICD-10 Finland

Syncope and collapse

2.0

14.3

168

887

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.9

14.3

236

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.5

14.3

138

H01

ICPC

Ear pain/earache

1.7

14.3

319

2040

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

14.3

2105

19764

R12

ICD-10 Finland

Heartburn

1.9

14.3

187

1024

S21

ICPC

Skin texture symptom/complaint

1.7

14.3

281

1738

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.8

14.3

264

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.8

14.3

270

NGE60

NOMESCO Finland

Plastic repair of patellar ligaments, open

4.8

14.2

G04CA02

ATC

tamsulosin; oral

2.5

14.2

370

L19

ICPC

Muscle symptom/complaint NOS

2.7

14.2

299

EMB10

NOMESCO Finland

Tonsillectomy

1.8

14.2

207

1175

N06AX05

ATC

trazodone; oral

2.7

14.1

294

WX290

NOMESCO Finland

Other blockage of nerve

1.4

14.1

1240

10456

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.5

14.1

144

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

14.1

184

1007

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.7

14.1

283

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

14.1

220

1274

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

14.1

915

7321

R35

ICD-10 Finland

Polyuria

2.4

14.1

421

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.2

14.1

123

582

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

14.1

455

3178

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

14.0

115

530

B03BA03

ATC

hydroxocobalamin; parenteral

2.6

14.0

307

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

3.5

14.0

140

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

14.0

112

511

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

5.5

14.0

R03AC12

ATC

salmeterol; inhalant

2.6

14.0

319

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

14.0

731

5622

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

3.3

14.0

160

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

13.9

667

5046

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

13.9

181

990

SPAT1395

SPAT

Health check-up of persons outside student and working life

2.8

13.9

240

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

13.8

248

1496

M07.3

ICD-10 Finland

Other psoriatic arthropathies

4.5

13.8

M03AX01

ATC

botulinum toxin; parenteral

3.1

13.7

193

SFA30

NOMESCO Finland

Three-surface restoration

1.4

13.7

869

6914

F93.89

ICD-10 Finland

Other childhood emotional disorders

3.6

13.7

123

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.8

13.6

229

1355

J01FA15

ATC

telithromycin; oral

1.8

13.6

225

1325

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

13.6

130

637

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

13.6

328

2138

R03AC13

ATC

formoterol; inhalant

2.3

13.6

107

485

G44.8

ICD-10 Finland

Other specified headache syndromes

3.0

13.6

194

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.0

13.6

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

13.6

100

441

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

13.5

102

454

OAB25, ,

SPAT

4.7

13.5

OAB44, ,

SPAT

1.8

13.5

226

1335

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

13.5

158

833

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.1

13.5

184

F32

ICD-10 Finland

Depressive episode

1.9

13.5

172

934

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.5

13.5

325

J01DA06

ATC

[U] cefuroxime

1.6

13.5

311

2005

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.7

13.5

115

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.7

13.5

267

NG1DA

NOMESCO Finland

X-ray of knees

4.0

13.4

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

13.4

257

1579

P80

ICPC

Personality disorder

5.1

13.4

XQ820

NOMESCO Finland

Exposure to medicinal substance

5.6

13.4

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

4.5

13.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

13.3

129

636

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

13.3

196

1116

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

13.2

340

S33.6

ICD-10 Finland

Sprain and strain of sacroiliac joint

13.9

13.2

ZYY01, ,

SPAT

9.7

13.2

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.8

13.2

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.1

13.2

120

577

D07AC01

ATC

betamethasone; topical

1.4

13.2

700

5387

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.4

13.2

141

M70.7

ICD-10 Finland

Other bursitis of hip

2.9

13.1

209

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.0

13.1

M25.4

ICD-10 Finland

Effusion of joint

3.8

13.1

108

M19.8

ICD-10 Finland

Other specified arthrosis

2.6

13.1

312

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

13.1

556

4102

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

4.8

13.1

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.9

13.1

204

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.2

13.0

116

553

C08CA05

ATC

nifedipine; systemic

2.4

13.0

398

M05BX04

ATC

denosumab; parenteral

2.6

13.0

289

R06AX26

ATC

fexofenadine; oral

1.8

13.0

199

1145

F32.8

ICD-10 Finland

Other depressive episodes

2.9

13.0

221

U02

ICPC

Urinary frequency/urgency

1.6

13.0

316

2064

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

6.2

12.9

H02AA02

ATC

fludrocortisone; oral

6.2

12.9

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.5

12.9

344

SXC05

NOMESCO Finland

Other oral or dental procedure

1.9

12.9

182

1021

N03AF02

ATC

oxcarbazepine; oral

2.6

12.9

308

SPAT1263

SPAT

Sampling

1.4

12.9

907

7324

L04

ICPC

Chest symptom/complaint

2.0

12.9

143

741

RF210, ,

NOMESCO Finland

2.6

12.9

285

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

12.8

297

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.6

12.8

303

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

12.8

243

1487

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

12.8

919

7445

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

12.8

343

2292

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

12.8

119

578

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.6

12.8

298

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.5

12.7

310

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

14.1

12.7

S80.0

ICD-10 Finland

Contusion of knee

1.8

12.7

193

1108

A06AC51

ATC

ispaghula, combinations; oral

2.3

12.7

100

454

E87.6

ICD-10 Finland

Hypokalaemia

2.9

12.7

213

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.5

12.7

323

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.1

12.7

123

607

R83

ICPC

Respiratory infection other

1.4

12.6

758

5952

N06AA12

ATC

doxepin; systemic

2.4

12.6

385

M77.0

ICD-10 Finland

Medial epicondylitis

2.6

12.6

288

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.1

12.6

119

581

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.5

12.6

336

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

5.5

12.6

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

12.6

373

ACC51

NOMESCO Finland

Release of median nerve

1.9

12.6

164

898

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.6

12.5

283

M01CB01

ATC

sodium aurothiomalate; parenteral

4.2

12.5

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

+∞

12.5

M01AB01

ATC

indometacin; systemic, rectal

2.6

12.5

295

K04.0

ICD-10 Finland

Pulpitis

1.7

12.5

262

1647

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.3

12.5

146

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

130.7

12.4

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

5.0

12.4

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

12.4

121

598

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

12.4

103

478

U07

ICPC

Urine symptom/complaint other

2.0

12.4

139

723

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.0

12.4

RF220, ,

NOMESCO Finland

4.0

12.4

R13

ICD-10 Finland

Dysphagia

2.1

12.4

120

592

SPAT1360

SPAT

Extensive global examination

2.0

12.4

128

647

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.6

12.3

285

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.3

12.3

421

K08.3

ICD-10 Finland

Retained dental root

2.1

12.3

117

573

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

12.3

316

2090

A92

ICPC

Allergy/allergic reaction NOS

2.2

12.3

105

493

SPAT1235

SPAT

Mental health, emotional support

3.9

12.3

R09

ICPC

Sinus symptom/complaint

1.7

12.2

255

1601

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

37.7

12.2

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.8

12.2

212

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.3

12.2

423

K11.2

ICD-10 Finland

Sialoadenitis

2.5

12.2

323

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.3

12.2

404

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

4.4

12.2

SBA10

NOMESCO Finland

Measurement of salivary flow rate

4.4

12.2

Z01.7

ICD-10 Finland

Laboratory examination

1.6

12.2

311

2054

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

16.0

12.1

N02CD02

ATC

galcanezumab; parenteral

4.6

12.1

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

12.1

159

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.0

12.1

140

736

S22.3

ICD-10 Finland

Fracture of rib

2.1

12.1

108

516

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.3

12.1

380

L84

ICPC

Back syndrome without radiat pain

2.1

12.0

112

544

B01AA03

ATC

warfarin; systemic

2.0

12.0

140

739

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

11.9

135

704

EBA00

NOMESCO Finland

Extraction of tooth

1.4

11.9

778

6182

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.7

11.9

243

H02BX01

ATC

methylprednisolone, combinations; systemic

2.7

11.9

249

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

2.4

11.9

345

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

11.9

163

907

D11

ICPC

Diarrhoea

1.6

11.9

324

2172

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.1

11.9

161

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.7

11.9

238

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

11.9

162

900

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

2.9

11.8

188

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

11.8

227

M25.8

ICD-10 Finland

Other specified joint disorders

5.4

11.8

S73.1

ICD-10 Finland

Sprain and strain of hip

5.4

11.8

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

11.8

100

468

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

11.8

213

1286

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.2

11.7

456

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.1

11.7

118

591

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.5

11.7

117

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.2

11.7

103

490

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

11.7

187

1091

TQW40, ,

SPAT

1.9

11.7

149

810

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

4.0

11.7

K07.6

ICD-10 Finland

Temporomandibular joint disorders

3.9

11.6

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

11.6

270

H93.1

ICD-10 Finland

Tinnitus

2.0

11.6

129

669

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

11.6

734

5798

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

23.0

11.6

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

11.6

236

1473

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

11.5

433

NHF25

NOMESCO Finland

Operation for debridement of ankle joint, arthroscopic

4.2

11.5

I49.1

ICD-10 Finland

Atrial premature depolarization

2.5

11.5

283

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.9

11.5

191

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.3

11.5

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.1

11.5

159

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

11.5

113

561

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

11.5

467

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.6

11.4

272

1764

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

11.4

177

1022

ZXD20

NOMESCO Finland

Day surgery

1.6

11.4

266

1716

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.0

11.4

132

694

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

11.4

195

1159

N28

ICPC

Limited function/disability (N)

4.1

11.4

C05AA08

ATC

fluocortolone; rectal, topical

1.7

11.4

237

1486

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

11.4

442

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

11.4

208

1260

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.9

11.4

176

WX204

NOMESCO Finland

Axillary plexus blockaced

2.5

11.4

285

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

11.3

486

3579

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.0

11.3

171

K59.01

ICD-10 Finland

Constipation outlet obstruction type

3.6

11.3

105

A07EA06

ATC

budesonide; oral, local oral

2.3

11.3

398

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.9

11.3

153

848

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.2

11.2

135

OAB42, ,

SPAT

1.7

11.2

242

1531

R01AD11

ATC

triamcinolone; nasal

1.7

11.2

199

1196

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.6

11.2

263

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.9

11.2

183

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

11.2

213

1305

M06

ICD-10 Finland

Other rheumatoid arthritis

5.6

11.2

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

11.2

326

2218

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

11.1

202

1222

J01CA08

ATC

pivmecillinam; oral

1.4

11.1

1108

9390

M01CB03

ATC

auranofin; oral

8.1

11.1

XQ802

NOMESCO Finland

Epicutan test

2.0

11.1

120

617

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.3

11.0

351

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

11.0

442

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

10.9

214

1321

D19

ICPC

Teeth/gum symptom/complaint

1.4

10.9

680

5347

Z30.2

ICD-10 Finland

Sterilization

1.6

10.9

288

1916

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.3

10.9

347

A01AB09

ATC

miconazole; local oral

1.8

10.9

157

888

K92.1

ICD-10 Finland

Melaena

2.5

10.9

267

K59.0

ICD-10 Finland

Constipation

2.1

10.9

104

511

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

10.9

177

1038

D07AC13

ATC

mometasone; topical

1.4

10.8

577

4415

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

10.8

139

757

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

10.8

373

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

2.6

10.8

238

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

3.7

10.8

Z2221

NOMESCO Finland

Medical doctor

1.4

10.8

594

4571

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.5

10.8

274

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

10.7

105

520

WVA30, ,

SPAT

2.2

10.7

420

XX9XE

NOMESCO Finland

Other ultrasound examination

4.7

10.7

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.0

10.7

150

J01MA14

ATC

moxifloxacin; systemic

1.8

10.6

150

842

R52.0

ICD-10 Finland

Acute pain

2.2

10.6

422

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

3.2

10.6

135

M01AG01

ATC

mefenamic acid; oral

2.4

10.6

301

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.2

10.6

377

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.5

10.5

271

A07EC02

ATC

mesalazine; oral, rectal

2.0

10.5

115

593

N05BA12

ATC

alprazolam; oral

1.7

10.5

202

1241

SPAT1254

SPAT

Administration of medicine

1.6

10.5

269

1776

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.2

10.5

372

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

10.4

D07AA02

ATC

hydrocortisone; topical

1.5

10.4

336

2334

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

10.4

369

2616

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.0

10.4

158

T93.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of lower limb

4.2

10.4

J30.3

ICD-10 Finland

Other allergic rhinitis

2.0

10.4

107

541

K11.7

ICD-10 Finland

Disturbances of salivary secretion

32.7

10.3

NHE15

NOMESCO Finland

Suture or reinsertion of ligament of ankle

3.8

10.3

E000006, ,

ATC

1.9

10.3

140

777

W0A10

NOMESCO Finland

Mapping of psychosocial situation

10.6

10.3

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

10.3

198

1217

A97

ICPC

No disease

1.5

10.3

365

2587

A99

ICPC

Disease/condition unspecnature/site

1.7

10.2

171

1010

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.8

10.2

160

927

C03DA01

ATC

spironolactone; oral

1.9

10.2

134

736

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

10.2

219

1385

N81.1

ICD-10 Finland

Cystocele

1.9

10.2

120

636

M12.3

ICD-10 Finland

Palindromic rheumatism

13.2

10.2

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

13.2

10.2

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

10.1

270

Y96.9

ICD-10 Finland

Unspecified type of accident

3.0

10.1

144

Z13.6

ICD-10 Finland

Special screening examination for cardiovascular disorders

5.3

10.1

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

5.3

10.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

10.1

177

1060

N05AX12

ATC

aripiprazole; systemic

1.9

10.1

123

659

1410

FHL

Laparoscopy

2.4

10.1

283

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.7

10.1

194

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

3.1

10.1

134

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

10.1

134

739

SPAT1311

SPAT

Counselling and guidance related to occupational health

2.1

10.1

485

K58

ICD-10 Finland

Irritable bowel syndrome

2.2

10.1

359

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

10.1

271

1809

N04BC09

ATC

rotigotine; transdermal

11.3

10.0

GX2D5

NOMESCO Finland

Sleep oximetry

5.0

10.0

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

5.0

10.0

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

10.0

124

R5599, ,

SPAT

9.2

10.0

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

10.0

522

3973

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.7

10.0

195

L14

ICPC

Leg/thigh symptom/complaint

1.8

10.0

147

837

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.1

9.9

440

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

9.9

285

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

9.9

219

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

9.9

127

692

N06AG02

ATC

moclobemide; oral

2.2

9.9

368

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

2.0

9.9

495

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.8

9.9

168

TEG00

NOMESCO Finland

Punction of mandibular joint

12.2

9.8

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

12.2

9.8

QDH05

NOMESCO Finland

Correction of deformity of toe nail

12.2

9.8

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

9.8

178

1075

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

9.8

351

2488

L10

ICPC

Elbow symptom/complaint

1.9

9.8

121

651

OAA65, ,

SPAT

1.4

9.8

515

3923

XG460

NOMESCO Finland

Short time oxymetry

4.0

9.8

N06AA04

ATC

clomipramine; systemic

3.1

9.8

126

R03BC03

ATC

nedocromil; inhalant

1.8

9.8

136

761

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

9.8

108

560

W19

ICD-10 Finland

Unspecified fall

1.7

9.8

163

963

K29.7

ICD-10 Finland

Gastritis, unspecified

2.4

9.7

294

K04

ICPC

Palpitations/awareness of heart

1.9

9.7

114

603

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

9.7

332

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.1

9.7

132

NDF25

NOMESCO Finland

Operation for osteochondritis of joint of wrist, arthroscopic

4.2

9.6

XKC03

NOMESCO Finland

Water cystometry

2.7

9.6

193

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

9.6

124

677

B81

ICPC

Anaemia vit B12/folate deficiency

2.7

9.6

182

SFA00

NOMESCO Finland

Small restoration

1.5

9.6

299

2061

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.6

9.6

211

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

9.6

301

2078

NXL00

NOMESCO Finland

Biopsy of muscle

11.4

9.6

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.5

9.5

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

4.5

9.5

R01AD01

ATC

beclometasone; nasal

1.5

9.5

331

2332

NG2AA

NOMESCO Finland

Patella X-ray examination

2.7

9.5

194

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.8

9.5

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

9.5

490

3716

D02

ICPC

Abdominal pain epigastric

1.8

9.5

147

849

WW200

NOMESCO Finland

Immunization

2.6

9.5

212

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.9

9.5

113

601

S01GX08

ATC

ketotifen; ophthalmic

1.9

9.5

127

702

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

9.5

428

Z06

ICPC

Unemployment problem

3.5

9.5

Z29

ICPC

Social problem NOS

2.5

9.5

236

LCA16

NOMESCO Finland

Destruction of endometrium

2.7

9.4

195

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.0

9.4

134

Q76.9

ICD-10 Finland

Congenital malformation of bony thorax, unspecified

100.5

9.4

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

9.4

702

5653

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.9

9.4

KMAK, ,

NOMESCO Finland

1.3

9.4

1221

10645

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

17.6

9.4

XLD00, ,

SPAT

2.5

9.4

219

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.6

9.4

M01AB16

ATC

aceclofenac; oral

2.7

9.4

190

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.0

9.4

105

547

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.2

9.4

344

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

2.3

9.3

325

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

3.8

9.3

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.2

9.3

109

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.5

9.3

244

N76.0

ICD-10 Finland

Acute vaginitis

1.6

9.3

246

1634

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

2.9

9.3

146

EGA00

NOMESCO Finland

Arthroscopy of mandibular joint

8.7

9.3

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

3.0

9.3

130

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

9.3

637

5063

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.7

9.3

174

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

9.3

214

1377

N06AA06

ATC

trimipramine; systemic

2.6

9.2

203

N17

ICPC

Vertigo/dizziness

1.6

9.2

213

1371

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

3.2

9.2

115

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

13.7

9.2

M01AC01

ATC

piroxicam; systemic, rectal

1.7

9.1

188

1175

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

9.1

115

623

L04AD01

ATC

ciclosporin; systemic

2.9

9.1

142

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

3.1

9.1

126

P19

ICPC

Drug abuse

3.6

9.1

EB1WA, ,

NOMESCO Finland

5.0

9.1

U29

ICPC

Urinary symptom/complaint other

2.5

9.1

217

R5140, ,

SPAT

4.6

9.1

NDG71

NOMESCO Finland

Arthrodes of first MP joint

11.5

9.1

L04AB05

ATC

certolizumab pegol; parenteral

4.0

9.1

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

9.0

182

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.0

9.0

132

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.6

9.0

188

M75.8

ICD-10 Finland

Other shoulder lesions

2.0

9.0

478

L50.3

ICD-10 Finland

Dermatographic urticaria

2.5

9.0

230

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.9

9.0

138

N06AB05

ATC

paroxetine; oral

1.8

9.0

138

796

R4180

NOMESCO Finland

Podiatric therapy

3.9

9.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

9.0

357

H02

ICPC

Hearing complaint

1.7

8.9

159

956

ZXD05

NOMESCO Finland

Urgent procedure

1.4

8.9

633

5050

RF421, ,

NOMESCO Finland

7.5

8.9

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.9

8.9

144

SGA01

NOMESCO Finland

Emergency treatment

1.4

8.9

401

2967

W10

ICD-10 Finland

Fall on and from stairs and steps

2.0

8.9

452

U71

ICPC

Cystitis/urinary infection other

1.7

8.9

157

942

A13

ICPC

Concern/fear medical treatment

3.0

8.9

128

M19.2

ICD-10 Finland

Other secondary arthrosis

3.7

8.9

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

3.9

8.9

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

8.8

100

523

C08CA01

ATC

amlodipine; oral

1.4

8.8

403

2989

K02

ICD-10 Finland

Dental caries

1.7

8.8

157

944

N02CD06

ATC

rimegepant; oral

4.5

8.8

NHE20

NOMESCO Finland

Plastic repair of capsule or ligament of ankle joint with transplant

6.8

8.8

F29

ICPC

Eye symptom/complaint other

1.6

8.8

198

1265

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.5

8.8

208

F50.1

ICD-10 Finland

Atypical anorexia nervosa

3.5

8.8

WX199

NOMESCO Finland

Other local analgesia

2.7

8.8

179

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

8.8

169

1038

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

8.8

434

J05AB01

ATC

aciclovir; systemic

1.4

8.8

467

3558

R63.4

ICD-10 Finland

Abnormal weight loss

2.4

8.8

245

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

8.7

178

1110

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.7

8.7

XQ801

NOMESCO Finland

Intracutantest

4.1

8.7

XA420

NOMESCO Finland

Extensive sleep examination

4.1

8.7

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

817

2768

4.05

207.63

1.6

1.3

396.20

382.86

titre

0.11

158

483

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

937

3539

3.81

202.27

1.5

1.3

15.42

9.39

u/ml

0.76

449

1532

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

931

3692

3.58

183.23

1.5

1.3

28.56

23.66

iu/ml

0.44

272

1154

(3015171) Extractable nuclear Ab [Units/volume] in Serum

369

755

5.64

175.18

1.3

1.2

0.27

0.44

u/ml

0.65

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

882

3949

3.02

133.49

2.1

1.9

102.56

155.20

u/l

2.38

844

3750

(3013707) Erythrocyte sedimentation rate by Westergren method

1943

13607

4.01

127.21

6.4

3.4

9.02

9.61

mm/h

2.19

1875

12755

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1882

12978

3.66

124.82

8.1

6.2

70.95

73.12

u/l

2.42

1825

12258

(3006315) Basophils [#/volume] in Blood

1499

9175

2.87

121.59

7.4

5.4

0.04

e9/l

0.61

1371

8062

(3019198) Lymphocytes [#/volume] in Blood

1534

9535

2.89

120.20

7.4

5.4

2.06

1.98

e9/l

3.03

1429

8637

(3001604) Monocytes [#/volume] in Blood

1490

9162

2.83

118.48

7.4

5.4

0.53

0.52

e9/l

1.15

1371

8073

(3013650) Neutrophils [#/volume] in Blood by Automated count

1630

10515

2.96

117.99

9.5

8.1

3.97

3.92

e9/l

0.43

1500

9275

(3013115) Eosinophils [#/volume] in Blood

1521

9522

2.82

115.50

7.6

5.6

0.18

e9/l

0.11

1419

8526

(40760892) CBC W Ordered Manual Differential panel - Blood

1420

8590

2.75

115.36

7.9

5.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1229

7158

2.57

104.01

5.0

5.5

1.22

mmol/l

1.56

1091

6093

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1277

7679

2.52

99.32

2.9

2.2

74.77

74.11

nmol/l

0.37

1215

7178

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1097

6361

2.41

89.47

4.6

4.8

1.22

mmol/l

0.62

1025

5853

(3022096) Basophils/100 leukocytes in Blood

1307

8247

2.38

86.95

7.6

5.4

0.67

0.68

0.28

1248

7694

(3019069) Monocytes/100 leukocytes in Blood

1345

8654

2.36

84.64

7.8

5.6

7.97

7.88

0.59

1292

8145

(3006504) Eosinophils/100 leukocytes in Blood

1338

8592

2.36

84.55

7.5

5.4

2.62

2.76

2.02

1284

8057

(3018010) Neutrophils/100 leukocytes in Blood

1370

8924

2.35

83.19

7.2

5.2

55.39

56.15

1.87

1313

8417

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

225

560

4.35

82.43

1.8

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

1380

9044

2.35

82.21

7.5

5.3

30.84

29.93

2.91

1328

8543

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

205

499

4.42

77.19

1.7

1.2

0.22

0.24

g/l

1.65

192

464

(3036481) Cortisol [Moles/volume] in Serum or Plasma

442

1780

2.84

75.84

2.3

2.0

359.35

383.31

nmol/l

1.63

417

1639

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

208

519

4.31

75.81

1.7

1.2

1.20

1.22

g/l

0.37

196

483

(3002582) Erythrocytes [#/volume] in Urine

838

4622

2.29

73.08

3.6

2.6

48.93

83.04

e6/l

0.41

715

3423

(3005719) IgG [Mass/volume] in Serum or Plasma

344

1229

3.12

73.03

3.3

2.4

9.71

10.29

g/l

2.81

320

1132

(3008898) HLA-B27 [Presence]

310

1044

3.28

72.66

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1258

8234

2.19

70.98

5.2

8.79

9.59

umol/l

3.59

1197

7734

(3018095) Leukocytes [#/volume] in Urine

986

5875

2.20

70.52

4.4

3.1

52.74

77.34

e6/l

0.88

776

3782

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

890

5102

2.23

69.98

2.9

2.4

55.23

55.61

u/l

0.04

844

4726

(40758558) Short blood count panel - Blood

814

4530

2.24

68.55

6.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

976

5869

2.16

67.38

2.0

1.7

100.67

98.34

pmol/l

0.91

546

3104

(3048689) Calprotectin [Mass/mass] in Stool

600

2963

2.39

66.69

2.6

2.4

110.52

95.86

ug/g

0.51

488

2330

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

193

502

4.11

66.37

1.3

1.1

7.36

2.47

u/ml

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1360

9372

2.13

64.71

4.1

3.9

5.96

6.30

mmol/l

13.13

1297

8461

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

176

436

4.29

64.57

1.3

1.1

11.36

2.96

u/ml

0.71

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

174

428

4.32

64.43

1.3

1.1

2.12

1.93

u/ml

0.12

(3024561) Albumin [Mass/volume] in Serum or Plasma

1011

6261

2.11

63.62

4.3

4.2

37.07

36.89

g/l

0.56

955

5854

(3022217) INR in Platelet poor plasma by Coagulation assay

954

5784

2.12

63.46

8.7

7.1

1.08

inr

0.05

345

1908

(3018418) pH of Serum or Plasma

759

4212

2.21

63.39

3.3

7.39

7.40

0.56

122

827

(3035350) Ketones [Presence] in Urine by Test strip

1343

9347

2.07

60.47

4.5

3.1

0.00

estimate

0.80

284

1922

(3026782) Osmolality of Urine

586

2991

2.29

59.43

3.5

2.4

506.39

530.56

mosm/kgh2o

1.79

540

2562

(3021601) Nitrite [Presence] in Urine by Test strip

1340

9358

2.06

59.27

5.9

4.2

0.00

estimate

0.50

281

1868

(3037467) Urinalysis macro (dipstick) panel - Urine

1696

12950

2.23

59.00

5.3

3.7

—

(3030467) Casts [#/volume] in Urine by Automated count

745

4205

2.15

58.76

3.4

2.6

0.16

0.31

e6/l

4.35

618

3095

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

348

1404

2.75

58.46

2.3

13.78

24.82

au/ml

2.28

146

(3021589) Normoblasts [#/volume] in Blood

1227

8350

2.02

57.74

9.7

7.6

0.00

e9/l

0.69

1046

6826

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

161

406

4.19

57.60

1.2

1.1

11.34

18.99

u/ml

—

(3009261) Glucose [Presence] in Urine by Test strip

1342

9439

2.03

57.42

4.6

3.1

0.00

0.01

estimate

1.32

281

1837

(3019550) Sodium [Moles/volume] in Serum or Plasma

2144

18437

4.05

55.80

14.0

9.6

139.68

139.62

mmol/l

0.71

2121

17909

(3007164) IgA [Mass/volume] in Serum or Plasma

775

4516

2.09

55.61

1.7

1.4

1.93

2.11

g/l

4.11

524

2854

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

833

4994

2.06

55.25

3.0

2.5

14.43

44.35

ng/l

1.80

379

2197

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

137

316

4.55

54.97

1.2

1.1

1.34

6.00

u/ml

0.47

(3023103) Potassium [Moles/volume] in Serum or Plasma

2145

18502

4.01

54.45

14.0

9.7

3.89

3.90

mmol/l

2.07

2119

17918

(4034850) Laboratory test

193

575

3.58

54.42

9.5

7.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

686

3846

2.12

54.30

2.1

2433.33

3105.96

umol/l

0.24

627

3471

(3000850) Epithelial cells [#/volume] in Urine

595

3195

2.17

52.37

2.8

2.3

6.98

9.09

e6/l

2.22

554

2841

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

727

4268

2.04

50.10

2.5

2.1

2.70

2.73

mg/l

0.18

650

3678

(3015377) Calcium [Moles/volume] in Serum or Plasma

845

5239

1.98

49.80

2.8

3.1

2.34

2.35

mmol/l

1.63

779

4779

(3028026) IgM [Mass/volume] in Serum or Plasma

256

955

2.89

49.49

2.1

1.8

1.26

1.36

g/l

0.72

239

888

(3017181) Myelocytes/100 leukocytes in Blood

323

1360

2.60

49.38

4.8

4.1

0.53

0.99

2.79

381

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

460

2274

2.28

49.31

3.1

2.3

5.41

4.77

e6/l

0.36

312

1119

(3025159) Blasts/100 leukocytes in Blood

304

1244

2.67

49.22

5.0

4.2

0.02

1.00

1.13

265

(3021440) Promyelocytes/100 leukocytes in Blood

313

1300

2.63

49.19

4.9

4.2

0.03

0.13

2.49

321

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

310

1298

2.61

47.86

1.3

22.85

34.86

au/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1944

16188

2.42

47.63

5.2

4.2

14.40

14.31

pmol/l

0.84

1860

15164

(3019150) Specific gravity of Urine by Refractometry

682

4005

2.01

46.30

4.5

3.3

1.01

1.02

kg/l

0.81

586

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2038

17400

2.71

46.22

13.0

8.4

93.82

92.33

ml/min/173m2

3.04

1829

14128

(3021960) Folate [Moles/volume] in Serum or Plasma

566

3108

2.09

46.21

1.5

1.4

20.43

21.13

nmol/l

0.58

522

2765

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

482

2491

2.19

46.03

2.3

2.6

548.03

623.13

ng/l

0.18

395

2001

(3030981) Hyaline casts [#/volume] in Urine by Automated count

197

662

3.16

45.67

2.8

2.4

0.16

0.22

e6/l

0.50

190

628

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2173

19280

4.13

44.78

17.1

9.8

15.42

18.83

mg/l

7.47

1858

14706

(36304419) Bacteria [Presence] in Urine

704

4255

1.95

43.48

3.3

2.5

—

(40768797) Stomach Pathology biopsy report

446

2297

2.17

42.65

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

335

1538

2.38

42.15

1.5

1.3

139.77

175.64

u/ml

0.66

313

1440

(3028192) IgG subclass 2 [Mass/volume] in Serum

172

5.22

41.87

1.6

1.4

2.80

2.91

g/l

0.23

122

(3024139) IgG subclass 3 [Mass/volume] in Serum

172

5.22

41.87

1.6

1.4

0.30

0.39

g/l

1.40

123

(3027135) IgG subclass 1 [Mass/volume] in Serum

173

5.19

41.59

1.6

1.4

6.38

6.23

g/l

0.12

124

(4062490) Immunoglobulin typing, IgG

175

5.13

41.05

1.8

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

926

6207

1.83

40.85

3.2

2.9

25.69

29.54

u/l

3.97

901

5931

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1055

7359

1.81

40.77

4.7

3.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

419

2148

2.17

40.34

3.0

3.2

0.82

0.83

mmol/l

0.07

390

2031

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2089

18318

2.81

39.96

6.2

4.9

1.62

2.03

mu/l

2.05

2035

17387

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2200

19884

4.71

39.77

16.7

10.3

66.37

66.92

umol/l

0.84

2200

19878

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

835

5459

1.84

39.66

1.4

1.3

0.88

1.41

u/ml

0.77

268

1529

(3002179) Metamyelocytes/100 leukocytes in Blood

287

1262

2.46

39.61

4.0

3.9

0.32

0.73

2.90

331

(3023368) Bacteria identified in Blood by Culture

556

3188

1.99

39.45

3.9

3.7

—

(3029937) Albumin [Presence] in Urine by Test strip

769

4945

1.84

38.22

5.2

3.3

0.00

estimate

1.34

280

1853

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

451

2438

2.06

37.52

2.8

2.2

1.16

1.34

e6/l

0.31

298

1278

(3011397) Hemoglobin [Presence] in Urine by Test strip

672

4168

1.87

37.32

4.3

3.1

—

(3013512) EKG study

627

3808

1.89

37.15

3.2

2.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

234

963

2.59

37.05

1.7

1.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1359

10425

1.76

36.11

3.6

2.8

67.29

67.88

ug/l

0.06

1311

9874

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

455

2500

2.03

36.05

2.4

2.5

2.42

mmol/l

0.07

402

2180

(3024980) IgG subclass 4 [Mass/volume] in Serum

106

277

3.97

36.01

1.6

1.5

0.45

0.58

g/l

1.34

213

(3039162) Centromere protein B Ab [Units/volume] in Serum

200

4.54

35.91

1.2

1.1

24.41

34.46

u/ml

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1553

12415

1.80

35.41

5.4

3.8

281.75

854.25

e6/l

1.01

120

(3045414) Leukocytes [Presence] in Urine

204

808

2.68

34.84

1.9

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

411

2206

2.05

34.61

1.8

1.6

1059.49

1190.33

nmol/l

2.46

340

1708

(3004616) Nuclear Ab [Presence] in Serum

184

4.59

33.99

1.4

1.2

—

(3015736) pH of Urine

1050

7587

1.72

33.72

4.0

2.9

5.85

5.95

0.55

802

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

531

3153

1.89

33.20

1.7

1.5

104783035.03

38784107.99

pmol/l

0.65

460

2746

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

183

706

2.73

32.87

2.2

2.1

39.75

39.67

u/l

0.02

171

658

(3004789) Transferrin [Mass/volume] in Serum or Plasma

387

2068

2.05

32.85

2.3

2.2

2.52

2.49

g/l

0.51

368

1911

(3000330) Specific gravity of Urine by Test strip

185

720

2.71

32.67

3.4

2.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2196

20132

3.98

32.29

12.9

8.2

25.04

24.25

u/l

1.35

2170

19547

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1992

17479

2.16

31.45

4.0

3.5

5.56

5.62

mmol/l

1.77

1902

16409

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

128

419

3.18

30.88

1.8

1.5

360.00

320.00

titre

—

(3022948) Iron [Moles/volume] in Serum or Plasma

414

2314

1.97

30.79

2.4

2.2

15.09

14.49

umol/l

0.92

397

2154

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

666

4333

1.76

30.45

1.9

1.7

0.66

0.83

mg/l

1.96

497

3175

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

352

1868

2.05

30.28

2.4

2.3

23.72

23.81

0.04

315

1614

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

347

1863

2.02

28.81

2.6

2.5

5.62

5.76

umol/l

0.06

289

1564

(3019420) Tryptase [Mass/volume] in Serum or Plasma

131

4.92

28.63

1.4

5.13

6.31

ug/l

0.63

111

(3022145) Colonoscopy Study observation

343

1838

2.02

28.62

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

124

422

3.05

27.99

1.3

338.01

323.13

ug/g

0.28

200

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

134

4.81

27.88

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

134

4.81

27.88

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

134

4.81

27.88

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

134

4.81

27.88

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

134

4.81

27.88

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

759

5220

1.68

27.86

3.2

2.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

280

3.54

27.82

2.1

1.7

4629.22

11046.64

e6/l

1.98

206

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

135

4.77

27.63

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

196

850

2.43

27.58

1.6

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

417

2436

1.87

26.82

2.9

153.77

317.08

ng/l

0.78

176

1313

(3044640) Blood type and Crossmatch panel - Blood

809

5703

1.65

26.74

2.3

1.9

—

(3044889) 12 lead EKG panel

1405

11378

1.62

25.94

3.2

2.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

7.60

25.49

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

5.69

25.25

1.1

1.2

4.60

5.66

u/l

0.75

(40761535) Cells panel - Urine sediment

239

1173

2.16

25.05

3.9

3.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

181

791

2.40

25.00

1.9

2.5

67.45

67.31

g/l

0.11

168

740

(3024263) Appearance of Synovial fluid

6.88

24.64

2.3

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

363

2090

1.88

24.24

1.3

1.2

106.78

162.96

iu/ml

1.81

143

821

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

354

2029

1.88

23.95

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

190

870

2.29

23.57

3.1

3.5

4.35

4.76

kpa

2.66

183

843

(3014051) Protein [Presence] in Urine by Test strip

125

471

2.75

23.44

2.0

2.2

—

(3002032) Base excess in Venous blood by calculation

215

1047

2.16

22.93

3.2

4.1

1.91

1.78

mmol/l

0.24

189

873

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1793

15668

1.69

22.26

4.8

4.2

36.66

37.67

mmol/mol

7.29

1721

14810

(3003458) Phosphate [Moles/volume] in Serum or Plasma

293

1615

1.94

22.23

4.0

5.3

1.04

1.05

mmol/l

0.33

278

1515

(3021447) Carbon dioxide [Partial pressure] in Venous blood

214

1055

2.14

22.11

3.2

4.1

5.85

5.83

kpa

0.08

206

1025

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

333

3.00

21.58

1.7

1.3

20.06

6.15

iu/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

281

1545

1.93

21.45

2.8

3.4

4.58

4.56

pmol/l

0.06

257

1388

(3014111) Lactate [Moles/volume] in Serum or Plasma

205

1007

2.14

21.36

4.7

6.3

1.24

1.23

mmol/l

0.04

200

980

(3018677) aPTT in Platelet poor plasma by Coagulation assay

343

2021

1.82

21.08

2.1

29.09

29.24

0.25

330

1956

(3028707) Methadone [Presence] in Urine by Screen method

148

638

2.41

21.05

2.1

2.6

—

(3025941) Bacteria identified in Stool by Culture

241

1268

2.01

20.87

1.3

1.2

—

(3042936) Bacteria identified in Isolate by Culture

346

2051

1.81

20.83

2.0

1.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

207

3.51

20.63

1.2

1.3

0.52

0.54

nmol/l

0.21

201

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

4.91

20.16

2.6

2.8

393.77

826.95

u/ml

2.34

(3033658) Prothrombin time (PT) actual/Normal

592

4095

1.60

19.96

3.8

3.3

99.34

98.28

0.54

568

3976

(3038026) Centromere Ab [Units/volume] in Serum

104

4.59

19.87

1.3

1.1

15.62

23.44

u/ml

—

(3004588) Protein electrophoresis panel - Serum or Plasma

138

599

2.39

19.33

2.1

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

172

821

2.18

19.25

2.0

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

745

5474

1.54

19.13

4.0

2.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

227

1205

1.98

19.12

2.2

2.7

1.63

1.74

1.20

204

1077

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

138

605

2.36

18.90

1.5

1.6

0.02

0.15

iu/ml

0.77

108

(3007853) Bacteria identified in Skin by Aerobe culture

326

1954

1.78

18.79

1.9

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

116

4.21

18.18

1.1

0.14

8.49

nmol/l

0.86

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

274

1574

1.84

18.14

2.4

2.2

30.02

36.73

u/l

1.91

215

1316

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

305

2.89

18.09

1.5

2.5

125.68

255.29

ug/l

1.62

276

(3013139) Helicobacter pylori Ag [Presence] in Stool

240

1324

1.91

18.03

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

4.66

17.29

1.4

1.2

208.70

333.81

u/l

0.47

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

191

3.36

17.27

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

201

3.30

17.27

1.8

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

227

1250

1.91

17.12

3.2

4.1

214.32

240.39

u/l

2.11

218

1193

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

116

492

2.43

17.11

1.2

1.4

402.86

460.77

mg/l

1.00

111

470

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

187

968

2.02

16.88

2.9

3.5

64.13

73.72

ng/l

1.59

164

869

(3011288) Drugs identified in Urine by Screen method

191

997

2.00

16.84

2.6

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

591

4224

1.54

16.82

2.2

1.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

106

436

2.50

16.70

1.2

1.4

3.43

3.66

mmol/l

1.99

101

410

(3023520) Reticulocytes [#/volume] in Blood

164

813

2.10

16.64

1.8

2.6

71.89

73.09

e9/l

0.15

116

582

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

106

437

2.50

16.62

1.3

1.6

1774.72

9901.88

e6/l

0.46

351

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

314

2.77

16.60

1.3

1.2

—

(3022621) pH of Urine by Test strip

214

1169

1.92

16.53

2.7

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

228

1273

1.88

16.47

3.0

2.1

77.06

77.46

ml/min/173m2

0.05

472

(3020891) Body temperature

104

428

2.50

16.37

4.3

4.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

341

2.68

16.21

2.1

1.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

341

2.68

16.21

2.1

1.8

7.21

7.35

g/l

0.32

330

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

341

2.68

16.21

2.1

1.8

3.47

3.59

g/l

0.52

330

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

235

1332

1.85

16.19

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

103

425

2.49

16.13

2.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

118

3.96

16.12

2.3

2.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

105

438

2.47

16.06

1.3

1.5

26.14

18.86

e6/l

0.17

332

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1100

8962

1.44

15.98

2.6

2.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

217

3.10

15.88

1.3

1.2

—

34.00

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

328

2.69

15.81

2.1

1.8

2.79

2.90

g/l

0.52

317

(40761511) CBC panel - Blood by Automated count

2169

20516

2.35

15.62

14.2

9.2

—

(3000060) B lymphocytes [#/volume] in Blood

5.42

15.43

1.8

2.6

195.45

164.00

e6/l

0.34

(4200892) Spirometry reversibility

199

1087

1.91

15.36

1.5

1.4

—

(3011412) CD3 cells [#/volume] in Blood

158

3.41

14.95

1.9

2.8

1.61

1.30

e9/l

1.10

142

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

144

708

2.10

14.94

1.5

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

316

2.65

14.78

1.9

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

232

1358

1.79

14.35

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

210

3.01

14.20

1.8

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

303

2.63

13.86

2.3

2.0

0.29

0.57

g/l

0.60

283

(3021788) Differential panel - Synovial fluid

231

2.87

13.68

1.8

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

199

3.02

13.63

1.3

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1552

13664

1.43

13.54

3.4

2.8

38.04

34.36

u/l

1.33

1499

13064

(3020779) Urea [Moles/volume] in Serum or Plasma

173

943

1.90

13.43

4.2

7.4

5.97

7.10

mmol/l

2.43

167

916

(3009542) Hematocrit [Volume Fraction] of Blood

2249

21797

5.50

13.22

23.4

14.7

40.23

39.93

2.54

2203

20833

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

396

2722

1.55

13.07

1.7

1.44

1.35

2.46

348

2465

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

307

2.56

13.00

2.1

1.9

9.73

10.08

g/l

0.38

295

(3002385) Erythrocyte distribution width [Ratio]

1892

17362

1.54

12.94

18.5

11.8

14.24

14.23

0.04

1881

17065

(44813793) Dust mix specific IgE antibody measurement

184

3.04

12.90

1.1

—

(3045424) Erythrocytes [Presence] in Urine

273

2.65

12.89

1.6

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

119

578

2.12

12.76

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

118

574

2.11

12.61

1.3

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

5.50

12.59

1.8

2.0

—

(3024731) MCV [Entitic volume]

2250

21842

5.55

12.59

23.5

14.7

90.51

90.03

5.98

2241

21632

(3007461) Platelets [#/volume] in Blood

2249

21826

5.31

12.57

23.7

14.8

274.52

267.40

e9/l

6.37

2232

21403

(3010813) Leukocytes [#/volume] in Blood

2250

21844

5.53

12.54

23.7

14.8

6.85

6.67

e9/l

3.34

2229

21380

(3035941) MCH [Entitic mass]

2250

21844

5.53

12.54

23.5

14.7

30.13

29.99

3.62

2241

21632

(3026361) Erythrocytes [#/volume] in Blood

2250

21847

5.51

12.48

23.7

14.8

4.49

e12/l

0.09

2231

21395

(1761482) Bacteria [#/volume] in Urine by Culture

297

2.54

12.34

4.9

3.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

2250

21856

5.45

12.27

23.8

14.8

134.47

133.90

g/l

1.75

2244

21641

(3000494) Fungus identified in Specimen by Culture

299

1952

1.61

12.27

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

436

2.26

12.18

1.2

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

109

3.62

12.17

2.4

1.7

48.29

40.72

0.39

(3000991) Gas panel - Venous blood

169

944

1.85

12.16

5.3

7.7

—

(3044290) Cell count panel - Cerebral spinal fluid

411

2.29

12.13

1.3

1.6

—

(3023410) Appearance of Cerebral spinal fluid

213

2.82

12.10

1.6

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

118

584

2.08

12.06

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

564

4236

1.44

11.92

2.6

3.1

7.51

7.70

mmol/l

0.36

498

3739

(3004809) Band form neutrophils/100 leukocytes in Blood

177

2.98

11.86

2.4

2.8

0.92

1.50

1.12

162

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

121

3.43

11.80

1.7

2.9

530.76

525.17

e6/l

0.03

100

(1001926) Buprenorphine [Presence] in Urine by Screen method

192

1126

1.77

11.77

2.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

3.97

11.74

3.0

2.9

126.80

115.57

au/ml

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

11.14

11.53

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

126

650

1.99

11.50

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

193

2.84

11.30

1.0

1.1

202.21

210.43

mg/l

0.27

169

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

116

3.40

11.11

1.7

3.0

0.22

0.20

e9/l

0.22

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

201

2.78

11.05

1.1

27.70

33.16

mg/l

1.05

163

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

194

1162

1.73

11.05

2.7

3.1

1.23

mmol/l

0.23

164

997

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

373

2.27

10.82

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

215

2.69

10.80

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

144

3.10

10.76

1.0

1.1

1.05

u/l

0.03

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

166

2.93

10.67

1.5

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

747

5982

1.37

10.65

1.9

1.7

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

12.95

10.64

1.7

1.9

1.26

0.81

mg/l

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.62

10.64

1.1

1.2

0.32

0.29

g/l

1.37

(3047007) Chlamydophila sp Ab [Presence] in Serum

364

2.27

10.57

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

189

2.79

10.57

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

160

921

1.79

10.45

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

267

2.48

10.37

2.2

1.8

40.02

38.48

g/l

1.30

256

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

351

2.27

10.16

1.4

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

13.17

10.15

1.7

1.8

1.05

2.05

mg/l

—

(3027008) Opiates [Presence] in Urine

225

1435

1.63

10.10

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

147

835

1.81

10.04

1.6

—

(3028300) Cannabinoids [Presence] in Urine

225

1438

1.63

10.02

2.0

1.9

—

(3016879) Cocaine [Presence] in Urine

210

1320

1.65

9.99

1.9

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

137

766

1.84

9.85

2.1

2.0

4.50

5.18

ug/l

0.16

119

690

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

152

2.93

9.83

1.3

1.2

—

(1616796) Gas panel - Central venous blood

268

2.43

9.82

2.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.66

9.77

1.1

—

(40768443) Skin Pathology biopsy report

123

668

1.89

9.69

1.2

—

(3011985) Renin [Units/volume] in Plasma

204

2.64

9.68

2.2

1.7

29.47

45.77

mu/l

0.99

189

(3000764) Benzodiazepines [Presence] in Urine

222

1428

1.61

9.63

2.0

1.9

—

(3036180) Methadone [Presence] in Urine

133

3.04

9.55

2.1

2.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.82

9.50

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

4.24

9.38

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

115

619

1.90

9.32

1.6

1.5

—

(3009343) pH of Capillary blood

127

706

1.85

9.32

2.7

3.1

7.43

7.42

0.27

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

141

2.94

9.25

1.3

2.30

1.86

mmol/l

0.49

133

(3027944) Amphetamines [Presence] in Urine

218

1414

1.60

9.13

1.8

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

271

2.36

9.13

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

271

2.36

9.13

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

182

2.67

9.05

2.9

3.6

33.01

30.68

mu/l

0.11

175

(3020961) Endomysium IgA Ab [Titer] in Serum

193

1218

1.64

9.04

1.1

—

131.31

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

127

713

1.83

9.03

2.7

3.1

5.09

5.14

kpa

0.43

121

689

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

224

2.49

8.98

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

191

2919

0.62

8.93

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

181

1129

1.66

8.88

1.5

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

339

2.19

8.86

1.3

1.2

3.35

3.19

u/ml

0.04

109

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.62

8.83

1.4

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

151

2.82

8.76

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

409

2.07

8.66

1.1

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

141

2.87

8.65

2.2

1.7

40.82

55.22

1.10

(3021901) Oxygen saturation in Capillary blood

175

2.66

8.63

2.4

2.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.82

8.51

1.4

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

299

2115

1.48

8.41

2.3

2.2

5212.15

6400.78

u/l

0.27

844

(3023183) Ammonium ion [Moles/volume] in Plasma

232

2.40

8.35

3.2

3.1

30.34

33.42

umol/l

0.75

220

(3007566) Smooth muscle Ab [Titer] in Serum

480

1.96

8.21

1.3

75.00

91.40

titre

0.48

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

503

1.93

8.12

2.1

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

285

2011

1.48

8.11

1.3

24.20

25.90

iu/l

0.38

249

1716

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

120

685

1.79

8.11

2.7

3.0

1.75

1.43

mmol/l

0.61

501

(3019225) pH of Specimen

205

1350

1.57

8.05

2.9

3.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

170

2.62

8.03

1.2

0.62

1.36

u/ml

0.86

(40768804) Tissue Pathology biopsy report

927

7914

1.29

7.81

2.1

1.9

—

(3003396) Base excess in Arterial blood by calculation

185

1199

1.59

7.78

4.8

7.4

1.03

0.93

mmol/l

0.19

148

921

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

331

2.12

7.76

1.3

3.29

4.32

u/ml

0.41

130

(3027801) Oxygen [Partial pressure] in Arterial blood

185

1201

1.59

7.73

4.9

7.3

12.89

13.60

kpa

0.83

178

1152

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

185

1201

1.59

7.73

4.9

7.3

5.02

5.07

kpa

0.34

180

1150

(36660697) Celiac disease serology panel - Serum

269

1898

1.47

7.65

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

356

2.06

7.49

2.0

2.1

0.91

1.98

ug/l

0.66

330

(3016502) Oxygen saturation in Arterial blood

162

1027

1.62

7.47

5.3

8.1

95.76

96.32

0.48

156

994

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

189

2.46

7.43

1.5

1.4

338.39

386.23

pmol/l

0.36

171

(3017143) Hepatitis C virus Ab [Presence] in Serum

400

3051

1.38

7.35

1.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

100

3.03

7.20

1.8

2.3

22.18

217.36

ug/l

0.49

(3011897) Casein IgE Ab [Units/volume] in Serum

3.87

6.98

1.0

1.2

0.04

0.60

u/ml

0.78

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

106

611

1.77

6.97

1.6

2.1

86.75

4.53

iu/l

0.48

260

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

100

569

1.79

6.87

2.1

1.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.20

6.84

1.1

97.70

99.13

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

117

698

1.71

6.83

2.4

2.1

—

(3017732) Neutrophils [#/volume] in Blood

199

1355

1.51

6.74

2.4

2.3

5.30

4.95

e9/l

0.13

169

1200

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

156

2.53

6.69

1.0

1.1

3.02

9.14

iu/ml

—

(3049717) Cytology report of Urine Cyto stain

263

2.16

6.69

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

566

4606

1.31

6.65

2.1

—

(3035285) Chloride [Moles/volume] in Venous blood

116

2.78

6.64

2.3

1.9

107.09

106.10

mmol/l

0.81

116

(3041354) Potassium [Moles/volume] in Venous blood

116

2.78

6.64

2.3

1.9

3.92

3.91

mmol/l

0.06

116

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

102

591

1.76

6.61

1.5

1.4

26.71

22.49

u/l

0.54

507

(3003181) Sodium [Moles/volume] in Urine

170

2.44

6.53

2.2

1.5

70.03

70.39

mmol/l

0.02

150

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

484

1.83

6.46

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

165

2428

0.65

6.40

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

188

1281

1.51

6.35

2.5

2.2

0.23

g/l

0.06

168

1211

(3002079) Sodium [Moles/time] in 24 hour Urine

3.11

6.32

1.6

1.5

137.89

143.18

mmol/24h

0.14

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.01

6.23

1.1

102.40

95.45

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.01

6.23

2.3

3.4

153.07

208.90

umol/l

0.43

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

157

2.44

6.12

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

616

5117

1.28

6.10

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

387

1.89

5.97

1.1

1.4

84.13

108.14

u/ml

1.43

(3033705) Calcium.ionized [Moles/volume] in Venous blood

112

2.70

5.92

2.4

1.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

147

965

1.56

5.90

1.1

—

0.84

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.36

5.84

1.3

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

205

2.22

5.83

1.4

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

143

2.47

5.78

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

344

2661

1.35

5.71

1.9

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.85

5.67

1.1

—

(3010421) pH of Blood

337

1.93

5.66

2.4

2.8

7.42

0.39

302

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

424

3384

1.31

5.66

2.1

1.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

566

1.71

5.62

2.4

2.7

141.44

162.33

2.60

541

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

112

702

1.63

5.48

1.9

2.5

111.98

97.08

ng/l

0.11

613

(3021387) Prolactin [Units/volume] in Serum or Plasma

197

1398

1.45

5.45

1.5

1.6

289.09

306.07

mu/l

0.54

183

1242

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

2.69

5.34

1.1

—

(3036489) Thrombin time

111

699

1.62

5.33

1.9

2.3

20.17

21.07

1.80

582

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

454

1.77

5.32

1.2

1.3

258.57

249.52

u/ml

0.11

288

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1925

18359

1.32

5.29

4.2

3.7

2.92

2.90

mmol/l

0.49

1840

17425

(3019060) Gas panel - Arterial blood

105

655

1.63

5.24

3.3

6.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

204

2781

0.71

5.24

1.4

1.5

—

(3000492) Spirometry study

260

1951

1.38

5.24

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

311

1.92

5.23

2.2

1.9

5.80

5.19

mmol/24h

0.78

281

(3003888) Timothy IgE Ab [Units/volume] in Serum

594

1.66

5.21

1.1

6.49

5.62

u/ml

0.14

318

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

113

1725

0.64

5.20

1.4

—

(3002256) Pathology report gross observation

305

2350

1.34

5.19

1.2

—

(3028433) Virus identified in Specimen by Culture

3.35

5.16

1.1

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1444

0.61

5.14

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1450

0.61

5.06

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

245

2.02

5.05

2.5

2.3

17.13

16.88

0.17

118

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1449

0.61

5.04

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

122

2.48

5.04

1.3

1.2

242.86

197.60

titre

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1447

0.61

5.01

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

564

1.66

4.94

1.1

1.16

1.66

u/ml

0.47

275

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

361

1.82

4.93

2.7

3.5

54.02

56.65

1.15

361

(3013637) Mi-2 Ab [Presence] in Serum

5.44

4.91

1.3

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.44

4.91

1.3

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.44

4.91

1.3

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.44

4.91

1.3

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

103

652

1.61

4.87

1.2

1.1

3.28

3.07

u/ml

0.05

333

(3020682) Albumin/Creatinine [Ratio] in Urine

431

3512

1.28

4.87

3.1

3.8

5.38

9.83

mg/mmol

2.02

258

2228

(3014133) Dog dander IgE Ab [Units/volume] in Serum

490

1.70

4.85

1.1

2.29

3.91

u/ml

0.81

225

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

199

1451

1.41

4.76

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

157

2.25

4.76

1.6

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

120

2.44

4.72

1.5

3.6

—

(3012501) Base excess in Blood by calculation

280

1.91

4.70

2.6

1.71

2.48

mmol/l

2.12

168

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1904

18201

1.29

4.63

3.8

3.5

4.82

4.84

mmol/l

0.36

1829

17379

(3000093) Morphology [Interpretation] in Blood Narrative

104

2.52

4.55

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

195

1430

1.40

4.52

2.0

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

563

1.62

4.49

1.1

0.18

0.88

u/ml

2.28

242

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

455

1.69

4.49

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

105

1575

0.65

4.48

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

463

1.69

4.47

1.5

1.9

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.43

4.46

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

195

2.07

4.45

1.1

0.38

2.86

u/ml

0.87

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

194

1427

1.39

4.43

3.0

2.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.70

4.42

1.7

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

106

2.47

4.38

1.8

1.3

6081.53

79085.59

e6/l

0.63

(3030313) Adrenal Ab [Titer] in Serum

4.66

4.37

1.2

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

288

1.86

4.34

1.4

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1893

18127

1.27

4.24

3.7

3.5

1.50

1.54

mmol/l

3.44

1813

17254

(3017446) Testosterone [Moles/volume] in Serum or Plasma

582

1.59

4.17

2.3

1.8

7.56

8.12

nmol/l

0.26

526

(3023419) Bacteria identified in Sputum by Culture

134

2.26

4.16

2.6

2.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

253

1960

1.33

4.15

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

382

1.72

4.13

1.6

1.5

—

(3012516) Albumin [Mass/volume] in Urine

407

3362

1.26

4.07

2.7

3.2

389.99

268.85

mg/l

0.19

234

2113

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

155

2.15

4.06

1.2

1.1

1.07

1.04

ratio

0.70

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.57

4.05

3.6

3.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1822

17394

1.24

4.04

3.5

3.2

1.28

1.21

mmol/l

4.39

1748

16506

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

401

1.69

4.00

1.1

1.0

0.08

0.27

u/ml

1.28

108

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.83

3.95

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

292

1.80

3.87

3.7

5.2

800.75

305.46

iu/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

139

2.17

3.83

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

445

1.64

3.82

1.1

5.39

4.25

u/ml

0.19

176

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

133

2.20

3.80

1.4

2.0

33.41

31.80

1.52

133

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1225

0.64

3.79

1.5

—

(3003338) MCHC [Mass/volume]

1839

17613

1.23

3.73

19.1

12.4

332.10

332.18

g/l

0.16

1830

17485

(3037121) Protein [Mass/volume] in Urine

503

1.59

3.72

2.8

3.1

0.22

0.29

g/l

0.45

213

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.15

3.70

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.01

3.69

1.1

—

64.55

—

(3022313) Gas panel - Capillary blood

506

1.58

3.64

2.7

3.1

—

(3042517) Benzodiazepines panel - Urine

4.02

3.59

2.7

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

307

1.74

3.58

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.95

3.57

1.1

—

80.55

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

300

1.75

3.57

2.3

2.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

111

2.27

3.55

1.8

2.5

58.78

54.93

0.50

(3050129) First trimester maternal screen panel - Serum or Plasma

134

1834

0.71

3.54

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

317

1.72

3.49

1.1

—

(3008295) Osmolality of Serum or Plasma

138

2.12

3.49

1.3

1.7

282.32

280.66

mosm/kgh2o

0.19

116

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1188

0.65

3.46

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

626

1.51

3.45

1.4

1.5

0.37

0.46

nmol/l

0.70

513

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

419

1.62

3.42

2.3

6.7

1.70

1.55

0.38

388

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

160

2.01

3.40

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

5.73

3.34

1.1

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.93

3.30

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

3.94

3.28

1.2

1.1

—

u/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

263

1.76

3.28

2.9

2.5

—

(3005033) Fetal Nuchal fold Thickness US

1185

0.66

3.27

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

118

842

1.42

3.27

1.3

11.32

10.82

u/l

0.12

687

(3013293) Extractable nuclear Ab [Presence] in Serum

8.59

3.26

2.0

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.03

3.25

2.6

2.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

220

1.83

3.24

2.5

2.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

165

1.95

3.14

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.26

3.13

1.2

1.4

90.67

70.05

nmol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

112

2.16

3.06

1.4

1.2

—

(3051339) Copper [Moles/volume] in Blood

5.01

3.05

1.6

1.1

15.39

16.43

umol/l

—

(40757494) Bilirubin.total [Moles/volume] in Blood

2.51

3.04

1.7

3.3

—

15.15

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.85

3.02

1.7

1.2

83.57

103.97

ng/l

—

(3015183) Erythrocyte sedimentation rate

154

1.96

3.00

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.76

2.98

2.4

3.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

148

1.97

2.95

2.3

1.8

20.55

23.58

mg/l

0.16

(3004716) Salmonella sp identified in Stool by Organism specific culture

191

1497

1.30

2.94

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.25

2.93

1.1

1.0

0.05

0.01

u/ml

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.25

2.93

1.2

1.6

—

(3011648) Oxygen content in Venous blood

101

2.19

2.93

2.7

4.3

12.96

11.13

1.47

101

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

162

1245

1.32

2.87

1.6

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.51

2.87

1.1

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.68

2.87

1.0

—

(3001729) Color of Synovial fluid

6.68

2.87

2.0

2.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

546

1.48

2.83

6.7

8.3

24.10

24.12

mmol/l

0.02

534

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

540

1.48

2.78

2.2

2.9

3.17

3.52

g/l

2.19

511

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.18

2.77

1.1

1.32

2.46

u/ml

0.40

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

131

2.00

2.75

1.1

261.19

303.30

mg/l

2.41

118

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

152

1.92

2.75

1.3

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

188

1.82

2.75

1.1

1.0

0.08

0.25

u/ml

2.43

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.01

2.73

1.0

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

233

1.73

2.73

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

219

1.75

2.69

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.47

2.62

2.3

2.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.26

2.60

1.1

—

u/ml

—

(3007463) Buprenorphine [Presence] in Urine

4.68

2.59

2.6

3.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.87

2.54

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.23

2.54

1.8

1.4

99.99

76.62

nmol/24h

0.68

(40760888) Immunoglobulin light chains.free panel - Serum

164

1.84

2.53

3.9

4.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.61

2.53

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

100

1348

0.73

2.47

1.4

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.82

2.46

1.0

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

204

1.73

2.41

1.9

1.6

—

(3002619) Bacteria identified in Specimen by Culture

2.76

2.27

1.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

164

1.78

2.23

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.11

2.22

2.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.34

2.22

2.3

9.00

15.83

umol/l

2.41

(3006442) Creatine [Moles/volume] in Serum or Plasma

128

1.88

2.21

1.6

1.3

62.29

69.73

umol/l

1.22

128

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.51

2.18

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

101

1329

0.75

2.16

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

1.76

2.15

1.2

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

108

1.95

2.15

1.1

1.0

18.12

13.66

u/ml

0.35

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.17

2.14

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.91

2.07

1.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

124

1.86

2.07

3.1

2.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

375

1.48

2.04

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

254

1.59

2.04

2.3

3.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

286

1.55

2.03

2.4

2.2

132.95

131.50

g/l

0.21

220

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.41

2.02

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.11

2.02

1.1

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

194

1.66

1.96

1.5

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

1.99

1.95

1.2

1.7

130.78

127.27

nmol/l

0.17

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

210

1.63

1.95

1.7

2.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

218

1.62

1.94

4.2

3.7

20.62

39.83

mg/l

0.75

176

(3034860) Kappa light chains.free [Mass/volume] in Serum

218

1.62

1.94

4.2

3.7

23.84

54.44

mg/l

0.91

177

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.55

1.94

1.2

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.55

1.94

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

2.57

1.94

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.97

1.93

2.9

4.3

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.76

1.93

4.8

2.6

30.50

19.67

mg/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

242

1.58

1.93

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

251

1.56

1.90

3.6

4.4

0.35

0.38

u/ml

0.39

129

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

365

1.46

1.89

2.9

3.3

94.84

510.33

u/ml

0.55

309

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

158

0.38

1.88

19.8

12.8

859.00

825.59

nmol/l

—

151

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

114

1.85

1.87

2.0

2.2

—

(3009871) Measles virus Ab [Titer] in Serum

2.09

1.86

1.5

1.8

—

(3044927) Protein electrophoresis panel - Urine

2.09

1.86

1.3

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.86

1.86

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.03

1.85

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

206

1728

1.21

1.84

4.8

3.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.54

1.84

1.7

2.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.58

1.80

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

247

1.55

1.79

1.0

1.1

96.82

95.48

0.11

234

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.35

1.77

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

124

1.78

1.76

1.3

1.5

2.10

1.50

nmol/l

1.01

112

(3008536) Aspergillus sp Ab [Presence] in Serum

3.34

1.74

1.5

2.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

322

1.47

1.74

1.1

21.33

1490.75

iu/ml

0.56

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

241

1.54

1.73

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.30

1.70

1.0

0.12

0.15

u/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

133

1.74

1.70

1.3

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

180

1.62

1.66

1.7

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.16

1.66

2.0

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

220

1.55

1.65

1.4

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

135

1.71

1.62

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

540

1.34

1.62

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

158

1.65

1.62

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1715

16653

1.12

1.60

4.2

3.8

—

(3017509) Phencyclidine [Presence] in Urine

2.51

1.59

1.8

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.91

1.59

4.5

2.7

45.27

47.88

0.21

(46235355) HIV 1 and 2 tests - Meaningful Use set

697

6467

1.11

1.56

1.9

2.0

—

(3025577) Chromium [Mass/volume] in Blood

2.28

1.55

2.3

2.1

1.55

2.57

ug/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.11

1.55

1.0

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.11

1.55

1.1

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

184

1.58

1.54

2.4

3.7

17.97

1563.61

u/ml

0.62

174

(21494434) Karyotype in Bone marrow

1.93

1.54

1.1

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1075

0.77

1.54

1.4

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.34

1.52

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.60

1.51

1.3

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

201

1.55

1.51

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

201

1.55

1.51

1.5

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.86

1.50

1.0

1.2

—

(3000012) Reticulocyte production index

131

1.69

1.49

1.3

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

575

1.31

1.48

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.44

1.48

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

124

1.70

1.47

1.3

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.23

1.46

1.5

1.4

8.81

7.96

ug/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

403

4452

0.88

1.45

1.6

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.37

1.45

1.3

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.13

1.44

1.0

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.04

1.43

1.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

204

1.53

1.43

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.31

1.43

1.1

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

432

1.35

1.40

1.6

2.0

1.26

1.37

g/l

0.44

378

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.18

1.40

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

138

0.43

1.39

2.5

2.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

142

1.63

1.38

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.61

1.36

1.2

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

199

1.51

1.35

1.5

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

392

1.36

1.35

1.3

1.5

6.90

6.85

mmol/l

0.05

357

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

382

0.65

1.34

4.2

3.6

24.82

27.35

u/ml

0.12

371

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

200

1.51

1.32

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

1.81

1.31

3.7

3.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

121

1.66

1.30

1.1

96.53

89.78

0.55

(3017569) Oxygen content in Arterial blood

2.10

1.30

1.6

3.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

201

1.50

1.30

1.5

1.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.36

1.29

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.78

1.28

1.0

3.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.09

1.27

1.0

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.09

1.27

1.0

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.40

1.24

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

202

0.54

1.22

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

204

1.48

1.22

1.0

0.25

0.76

u/ml

0.88

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.64

1.21

1.0

1.2

—

33.00

—

(1002224) Polysomnography panel

114

946

1.22

1.21

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.73

1.21

1.1

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

172

1.52

1.20

1.3

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.31

1.18

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.31

1.18

1.0

6.00

7.87

u/ml

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.11

1.18

1.0

0.02

0.80

u/ml

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

475

4383

1.11

1.17

1.5

1.6

1.48

1.35

mmol/l

2.18

417

3826

(1761868) Lipid panel - Serum or Plasma

734

7778

0.92

1.17

2.5

2.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

248

1.42

1.17

5.1

6.1

326.03

376.59

umol/l

1.47

219

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.16

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.00

1.16

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.00

1.16

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

129

0.46

1.16

2.7

3.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.50

1.15

1.4

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

391

0.69

1.15

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

200

1.46

1.12

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

103

1235

0.83

1.12

1.7

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.71

1.11

2.1

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

792

1.22

1.10

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

152

1.52

1.09

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

126

1070

1.19

1.08

1.8

1.7

3.57

4.29

mg/l

0.47

100

746

(3020191) Ethanol [Moles/volume] in Serum or Plasma

145

1.52

1.06

1.8

1.7

1.83

1.44

promille

0.58

110

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

137

1.54

1.05

1.0

1.1

1974.29

1499.79

miu/ml

0.82

137

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.12

1.05

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.28

1.03

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

315

1.34

1.03

1.4

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.64

1.03

1.0

—

(3037756) Immunofixation for Serum or Plasma

146

1.51

1.03

1.5

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.92

1.02

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.88

1.00

1.1

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.88

1.00

1.1

1.9

—

(3004451) EKG impression Narrative

2.00

1.00

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.84

0.98

1.1

2.5

—

74685.50

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

442

1.27

0.97

1.4

1.2

—

(40768793) Breast Pathology biopsy report

570

0.77

0.97

1.2

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

125

1.52

0.94

2.1

2.7

0.27

1.55

g/24h

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

119

0.50

0.93

1.0

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

2.23

0.93

1.0

8.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.73

0.92

1.1

3.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

352

1.28

0.86

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

972

0.84

2.2

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

189

1.38

0.81

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

329

1.28

0.80

2.8

3.3

23.64

22.11

mg/l

0.11

211

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.67

0.78

1.2

—

66.67

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.78

0.0

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

157

1.41

0.76

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

149

1.41

0.75

2.0

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

315

1.27

0.75

1.4

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.09

0.74

1.0

1.2

1.34

1.59

umol/24h

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

0.72

2.2

2.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

407

1.23

0.72

1.3

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.67

0.72

1.3

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.75

0.71

1.0

0.04

1.25

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

702

1.17

0.71

1.0

1.1

0.83

3.87

u/ml

—

122

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.93

0.70

3.6

4.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.71

0.70

1.3

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

142

0.63

0.69

1.0

1.3

1.68

1.60

g/l

—

142

(3028717) Thiamine [Mass/volume] in Blood

1.85

0.68

1.0

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

317

0.75

0.66

2.2

2.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

111

1.44

0.66

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

111

1.44

0.66

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

111

1.44

0.66

1.4

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.54

0.65

1.0

1.1

—

(3034426) Prothrombin time (PT)

1.54

0.65

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.73

0.64

1.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

112

1.43

0.63

1.5

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

618

1.17

0.62

1.7

2.3

3.74

4.71

umol/l

1.37

460

(3002523) Influenza virus A Ag [Presence] in Specimen

467

0.81

0.61

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

113

1.42

0.61

1.4

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.48

0.60

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

466

0.81

0.60

1.2

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

131

1.38

0.59

2.2

2.8

40638.89

39858.47

ug/l

0.08

131

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.58

0.0

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

0.00

0.58

0.0

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.58

0.0

1.3

—

139.42

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

557

5329

1.06

0.57

1.6

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

127

1143

1.12

0.57

3.0

3.8

3.06

43.95

ug/l

0.72

838

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.48

0.57

1.3

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

274

0.76

0.56

1.7

2.6

26.39

128.64

ug/min

2.17

179

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

542

1.17

0.55

6.6

10.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.48

0.53

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

326

3451

0.94

0.52

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

232

1.25

0.52

1.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

232

1.25

0.52

1.3

1.4

—

(3003694) ABO and Rh group [Type] in Blood

682

6587

1.05

0.50

1.6

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.52

0.48

3.7

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

475

1.16

0.48

1.4

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.47

1.3

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.47

1.3

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

218

1.24

0.46

1.1

—

(4035726) Immunohistochemistry procedure

144

1325

1.09

0.45

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.59

0.45

1.4

1.5

38.38

36.12

g/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

201

1.25

0.45

1.4

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

131

0.69

0.43

4.0

7.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

284

0.81

0.42

1.1

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

176

1886

0.93

0.42

1.8

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.43

0.41

1.7

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.41

0.0

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

161

0.74

0.41

1.2

1.4

0.89

0.95

g/l

0.25

161

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

178

1664

1.08

0.40

6.3

4.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.47

0.40

1.0

1.4

183.80

361.44

pmol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

132

1.29

0.40

1.1

—

(4281824) Cell count and differential, peritoneal fluid

214

0.79

0.38

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

344

0.84

0.37

2.1

2.3

0.90

0.67

ug/l

0.22

168

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

651

0.89

0.37

1.2

—

(3047189) Immunofixation for 24 hour Urine

1.40

0.35

2.3

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

172

1.22

0.34

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

100

1.30

0.33

1.5

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

607

1.11

0.32

4.0

3.4

1.87

2.02

ug/l

0.06

553

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.28

0.32

3.8

2.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

133

1247

1.07

0.30

1.3

176.99

236.84

miu/ml

1.14

651

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

167

1766

0.94

0.30

3.7

3.4

31.05

32.48

1.01

132

1307

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

410

1.12

0.30

1.0

1.1

1.06

3.20

u/ml

2.40

233

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.27

0.27

1.9

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.25

0.27

1.9

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.23

0.27

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

104

1.25

0.26

1.6

2.0

1.50

2.75

u/field

—

(40768441) Liver Pathology biopsy report

123

1.22

0.25

1.3

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

406

1.11

0.25

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

413

0.89

0.24

1.6

7.39

7.62

mmol/l

0.37

399

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.73

0.24

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

169

0.83

0.24

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

254

0.86

0.23

1.5

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.25

0.22

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.75

0.22

1.1

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.22

1.2

3.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.22

1.2

3.3

—

(3025130) Human papilloma virus identified in Specimen

535

1.09

0.22

1.6

1.8

—

(3001556) Androgen free Index in Serum or Plasma

1.22

0.22

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.3

—

72.92

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.3

—

7.01

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

41.30

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.21

0.0

3.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.3

—

2.76

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.9

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.16

0.21

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.08

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

697

0.93

0.20

1.2

1.3

2.40

4.07

ug/l

2.89

652

(40765089) Chromosome analysis panel - Blood by G-banded

112

0.80

0.20

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

250

1.12

0.19

2.3

4.5

23.35

82.07

u/ml

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

165

1.15

0.19

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

165

1.15

0.19

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.15

0.19

2.7

2.0

—

151.55

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.13

0.18

1.3

57.98

157.69

pmol/l

—

(3047181) Lactate [Moles/volume] in Blood

386

1.09

0.18

2.5

7.3

1.16

1.14

mmol/l

0.05

335

(4146454) Self-monitoring of blood glucose

100

1.20

0.18

2.0

2.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.76

0.17

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

129

1.16

0.17

1.0

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.16

0.16

1.3

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.79

0.15

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.80

0.14

1.1

—

(3042631) Mycobacterium sp identified in Specimen

112

1.16

0.14

2.5

2.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

110

0.82

0.13

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

124

1.13

0.11

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

399

1.05

0.09

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

126

1.11

0.09

1.1

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.11

0.09

1.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

1.3

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

1.3

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.09

0.09

1.3

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.09

0.09

1.2

3.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

224

1.07

0.08

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

596

5910

1.01

0.08

1.6

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.83

0.07

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

468

0.96

0.07

4.1

3.3

20.51

22.74

0.58

162

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.88

0.06

1.4

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

284

2814

1.01

0.05

1.9

2.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

149

0.94

0.03

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

149

0.94

0.03

1.6

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

671

1.01

0.01

1.8

1.6

—

(40768795) Lymph node Pathology biopsy report

155

0.97

0.00

1.5

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

152

0.99

0.00

1.6

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

182

0.99

0.00

1.5

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

123

0.98

0.00

1.0

1.1

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

29.20

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

177.80

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

34.54

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

20.28

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

2.0

—

9.37

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.2

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

7.76

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.2

—

609.20

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.8

—

2.56

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.00

-0.00

0.0

1.3

—

74.07

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

7.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.94

-0.00

1.0

1.1

103.24

73.36

ug/l

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3006462) Nitrate [Presence] in Urine

0.94

-0.00

1.4

2.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.89

-0.00

4.6

2.2

97.71

154.75

nmol/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

6.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_HYPERMOBILITY and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_HYPERMOBILITY	0.823 [0.69, 0.99]	0.036
Birth year	0.995 [0.99, 1.0]	0.279

During the follow-up period (1.1.1998 — 31.12.2019), 192 out of 10095 females with M13_HYPERMOBILITY died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_HYPERMOBILITY.

N-year risk	Females	Males
1	0.072%	No data
5	0.416%	No data
10	1.087%	No data
15	2.289%	No data
20	4.021%	No data

Relationships between endpoints

↥

Index endpoint: M13_HYPERMOBILITY – Hypermobility syndrome

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypermobility syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints